| Human LocusID |
number of FANTOM2 clones | Mouse ortholog LocusID | Human Gene Symbol |
Phenotype | OMIM | GI | Human Chromosomal Position |
Human Gene Name (Disease Name) |
|---|---|---|---|---|---|---|---|---|
| 2 | 2 | 11287 | A2M | Emphysema due to alpha-2-macroglobulin deficiency | 103950 | 5 | 12p13.3-p12.3 | Alzheimer disease, susceptibility to; Emphysema due to alpha-2-macroglobulin deficiency |
| 12 | 17 | 19067 | SERPINA3 | Alpha-1-antichymotrypsin deficiency | 107280 | 8 | 14q32.1 | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
| 19 | 10 | 11303 | ABCA1 | Tangier disease | 600046 | 5 | 9q31.1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
| 24 | 11 | 11304 | ABCA4 | Cone-rod dystrophy 3 | 601691 | 5 | 1p22.1-p21 | ATP-binding cassette, sub-family A (ABC1), member 4 |
| 25 | 34 | 11350 | ABL1 | Leukemia, chronic myeloid | 189980 | 10 | 9q34.1 | v-abl Abelson murine leukemia viral oncogene homolog 1 |
| 33 | 11 | 11363 | ACADL | Acyl-CoA dehydrogenase, long chain, deficiency of | 201460 | 2 | 2q34-q35 | acyl-Coenzyme A dehydrogenase, long chain |
| 34 | 13 | 11364 | ACADM | Acyl-CoA dehydrogenase, medium chain, deficiency of | 607008 | 7 | 1p31 | acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain |
| 35 | 14 | 11409 | ACADS | Acyl-CoA dehydrogenase, short-chain, deficiency of | 606885 | 4 | 12q22-qter | acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain |
| 37 | 8 | 11370 | ACADVL | VLCAD deficiency | 201475 | 6 | 17p13-p11 | acyl-Coenzyme A dehydrogenase, very long chain |
| 38 | 7 | 110446 | ACAT1 | 3-ketothiolase deficiency | 203750 | 3 | 11q22.3-q23.1 | acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase) |
| 51 | 7 | 11430 | ACOX1 | Adrenoleukodystrophy, pseudoneonatal | 264470 | 7 | 17q24-17q25 | acyl-Coenzyme A oxidase 1, palmitoyl |
| 70 | 36 | 11464 | ACTC | Cardiomyopathy, familial hypertrophic | 102540 | 3 | 15q11-q14 | actin, alpha, cardiac muscle |
| 94 | 8 | 11482 | ACVRL1 | Hereditary hemorrhagic telangiectasia-2 | 601284 | 4 | 12q11-q14 | activin A receptor type II-like 1 |
| 100 | 1 | 11486 | ADA | Severe combined immunodeficiency due to ADA deficiency | 102700 | 7 | 20q12-q13.11 | adenosine deaminase |
| 154 | 12 | 11555 | ADRB2 | Asthma, nocturnal, susceptibility to | 109690 | 12 | 5q31-q32 | adrenergic, beta-2-, receptor, surface |
| 174 | 7 | 11576 | AFP | Hereditary persistence of alpha-fetoprotein | 104150 | 7 | 4q11-q13 | alpha-fetoprotein |
| 175 | 2 | 11593 | AGA | Aspartylglucosaminuria | 208400 | 8 | 4q32-q33 | aspartylglucosaminidase |
| 178 | 4 | 77559 | AGL | Glycogen storage disease IIIb | 232400 | 12 | 1p21 | amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme, glycogen storage disease type III) |
| 182 | 10 | 16449 | JAG1 | Tetralogy of Fallot | 601920 | 7 | 20p12.1-p11.23 | jagged 1 (Alagille syndrome) |
| 183 | 2 | 11606 | AGT | Hypertension, essential, susceptibility to | 106150 | 6 | 1q42-q43 | angiotensinogen (serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 8) |
| 185 | 1 | 11607 | AGTR1 | Hypertension, essential | 106165 | 14 | 3q21-q25 | angiotensin II receptor, type 1 |
| 185 | 1 | 11608 | AGTR1 | Hypertension, essential | 106165 | 14 | 3q21-q25 | angiotensin II receptor, type 1 |
| 203 | 3 | 11636 | AK1 | Hemolytic anemia due to adenylate kinase deficiency | 103000 | 3 | 9q34.1 | adenylate kinase 1 |
| 208 | 40 | 11652 | AKT2 | Ovarian carcinoma | 164731 | 3 | 19q13.1-q13.2 | v-akt murine thymoma viral oncogene homolog 2 |
| 210 | 2 | 17025 | ALAD | Lead poisoning, susceptibility to | 125270 | 6 | 9q34 | aminolevulinate, delta-, dehydratase |
| 212 | 8 | 11656 | ALAS2 | Anemia, sideroblastic/hypochromic | 301300 | 5 | Xp11.21 | aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia) |
| 213 | 7 | 11657 | ALB | Analbuminemia | 103600 | 10 | 4q11-q13 | albumin |
| 215 | 6 | 11666 | ABCD1 | Adrenoleukodystrophy | 300100 | 6 | Xq28 | ATP-binding cassette, sub-family D (ALD), member 1 |
| 217 | 14 | 11669 | ALDH2 | Alcohol intolerance, acute | 100650 | 7 | 12q24.2 | aldehyde dehydrogenase 2 family (mitochondrial) |
| 224 | 8 | 11671 | ALDH3A2 | Sjogren-Larsson syndrome | 270200 | 6 | 17p11.2 | aldehyde dehydrogenase 3 family, member A2 |
| 226 | 8 | 11674 | ALDOA | Aldolase A deficiency | 103850 | 11 | 16q22-q24 | aldolase A, fructose-bisphosphate |
| 229 | 8 | 11675 | ALDOB | Fructose intolerance | 229600 | 8 | 9q21.3-q22.2 | aldolase B, fructose-bisphosphate |
| 249 | 2 | 11647 | ALPL | Hypophosphatasia, infantile | 171760 | 5 | 1p36.1-p34 | alkaline phosphatase, liver/bone/kidney |
| 270 | 2 | 109673 | AMPD1 | Myoadenylate deaminase deficiency | 102770 | 3 | 1p13 | adenosine monophosphate deaminase 1 (isoform M) |
| 272 | 2 | 11717 | AMPD3 | AMP deaminase deficiency, erythrocytic | 102772 | 7 | 11p15 | adenosine monophosphate deaminase (isoform E) |
| 286 | 20 | 11733 | ANK1 | Spherocytosis-2 | 182900 | 15 | 8p11.1 | ankyrin 1, erythrocytic |
| 324 | 6 | 11789 | APC | Adenoma, periampullary | 175100 | 4 | 5q21-q22 | adenomatosis polyposis coli |
| 325 | 3 | 20219 | APCS | ?Amyloidosis, secondary, susceptibility to | 104770 | 6 | 1q21-q23 | amyloid P component, serum |
| 335 | 1 | 11806 | APOA1 | ApoA-I and apoC-III deficiency, combined | 107680 | 10 | 11q23-q24 | apolipoprotein A-I |
| 338 | 0 | 11809 | APOB | Abetalipoproteinemia | 107730 | 25 | 2p24-p23 | apolipoprotein B (including Ag(x) antigen) |
| 348 | 2 | 11816 | APOE | Sea-blue histiocyte disease | 107741 | 8 | 19q13.2 | apolipoprotein E |
| 350 | 1 | 11818 | APOH | Apolipoprotein H deficiency | 138700 | 9 | 17q23-qter | apolipoprotein H (beta-2-glycoprotein I) |
| 351 | 3 | 11820 | APP | Amyloidosis, cerebroarterial, Dutch type | 104760 | 8 | 21q21.3 | amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) |
| 353 | 1 | 11821 | APRT | Urolithiasis, 2,8-dihydroxyadenine | 102600 | 4 | 16q24 | adenine phosphoribosyltransferase |
| 355 | 1 | 14102 | TNFRSF6 | Squamous cell carcinoma, burn scar-related, somatic | 134637 | 4 | 10q24.1 | tumor necrosis factor receptor superfamily, member 6 |
| 356 | 1 | 14103 | TNFSF6 | Systemic lupus erythematosus, susceptibility | 134638 | 7 | 1q23 | tumor necrosis factor (ligand) superfamily, member 6 |
| 358 | 6 | 11826 | AQP1 | Colton blood group | 110450 | 8 | 7p14 | aquaporin 1 (channel-forming integral protein, 28kDa) |
| 359 | 8 | 11827 | AQP2 | Diabetes insipidus, nephrogenic, autosomal recessive | 107777 | 5 | 12q12-q13 | aquaporin 2 (collecting duct) |
| 367 | 2 | 11835 | AR | Prostate cancer, susceptibility to | 313700 | 13 | Xq11.2-q12 | androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) |
| 410 | 3 | 11883 | ARSA | Metachromatic leukodystrophy | 250100 | 4 | 22q13.33 | arylsulfatase A |
| 411 | 5 | 11881 | ARSB | Maroteaux-Lamy syndrome, several forms | 253200 | 5 | 5p11-q13 | arylsulfatase B |
| 435 | 2 | 109900 | ASL | Argininosuccinicaciduria | 207900 | 6 | 7cen-q11.2 | argininosuccinate lyase |
| 443 | 4 | 11484 | ASPA | Canavan disease | 271900 | 3 | 17pter-p13 | aspartoacylase (aminoacylase 2, Canavan disease) |
| 462 | 26 | 11905 | SERPINC1 | Antithrombin III deficiency | 107300 | 5 | 1q23-q25.1 | serine (or cysteine) proteinase inhibitor, clade C (antithrombin), member 1 |
| 487 | 3 | 11937 | ATP2A1 | Brody myopathy | 108730 | 2 | 16p12.1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
| 488 | 8 | 11938 | ATP2A2 | Darier disease | 108740 | 3 | 12q23-q24.1 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
| 525 | 4 | 110935 | ATP6V1B1 | Renal tubular acidosis with deafness | 192132 | 4 | 2p13.1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B, isoform 1 (Renal tubular acidosis with deafness) |
| 538 | 2 | 11977 | ATP7A | Cutis laxa, neonatal | 300011 | 2 | Xq13.2-q13.3 | ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome) |
| 540 | 1 | 11979 | ATP7B | Wilson disease | 606882 | 4 | 13q14.2-q21 | ATPase, Cu++ transporting, beta polypeptide (Wilson disease) |
| 546 | 5 | 22589 | ATRX | Alpha-thalassemia/mental retardation syndrome | 300032 | 14 | Xq13.1-q21.1 | alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) |
| 551 | 1 | 11998 | AVP | Diabetes insipidus, neurohypophyseal | 192340 | 9 | 20p13 | arginine vasopressin (neurophysin II, antidiuretic hormone, diabetes insipidus, neurohypophyseal) |
| 554 | 2 | 12000 | AVPR2 | Diabetes insipidus, nephrogenic | 304800 | 7 | Xq28 | arginine vasopressin receptor 2 (nephrogenic diabetes insipidus) |
| 581 | 1 | 12028 | BAX | Colorectal cancer | 600040 | 17 | 19q13.3-q13.4 | BCL2-associated X protein |
| 583 | 1 | 67378 | BBS2 | Bardet-Biedl syndrome 2 | 606151 | 4 | 16q21 | Bardet-Biedl syndrome 2 |
| 590 | 14 | 12038 | BCHE | Apnea, postanesthetic | 177400 | 5 | 3q26.1-q26.2 | butyrylcholinesterase |
| 593 | 1 | 12039 | BCKDHA | Maple syrup urine disease, type Ia | 248600 | 7 | 19q13.1-q13.2 | branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease) |
| 594 | 1 | 12040 | BCKDHB | Maple syrup urine disease, type Ib | 248611 | 7 | 6p21-p22 | branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease) |
| 595 | 4 | 12443 | CCND1 | Leukemia/lymphoma, B-cell, 1 | 168461 | 11 | 11q13 | cyclin D1 (PRAD1: parathyroid adenomatosis 1) |
| 596 | 2 | 12043 | BCL2 | Leukemia/lymphoma, B-cell, 2 | 151430 | 7 | 18q21.3 | B-cell CLL/lymphoma 2 |
| 604 | 4 | 12053 | BCL6 | Lymphoma, B-cell | 109565 | 4 | 3q27 | B-cell CLL/lymphoma 6 (zinc finger protein 51) |
| 605 | 3 | 77045 | BCL7A | B-cell non-Hodgkin lymphoma, high-grade | 601406 | 2 | 12q24.13 | B-cell CLL/lymphoma 7A |
| 611 | 2 | 12057 | OPN1SW | Colorblindness, tritan | 190900 | 3 | 7q31.3-q32 | opsin 1 (cone pigments), short-wave-sensitive (color blindness, tritan) |
| 613 | 1 | 110279 | BCR | Leukemia, chronic myeloid, Leukemia, acute lymphocytic | 151410 | 10 | 22q11.23 | breakpoint cluster region |
| 669 | 6 | 12183 | BPGM | Hemolytic anemia due to bisphosphoglycerate mutase deficiency | 222800 | 4 | 7q31-q34 | 2,3-bisphosphoglycerate mutase |
| 672 | 1 | 12189 | BRCA1 | Breast cancer-1 | 113705 | 19 | 17q21 | breast cancer 1, early onset |
| 686 | 2 | 26363 | BTD | Biotinidase deficiency | 253260 | 3 | 3p25 | biotinidase |
| 695 | 26 | 12229 | BTK | XLA and isolated growth hormone deficiency | 300300 | 13 | Xq21.33-q22 | Bruton agammaglobulinemia tyrosine kinase |
| 712 | 1 | 12259 | C1QA | C1q deficiency, type A | 120550 | 2 | 1p36.3-p34.1 | complement component 1, q subcomponent, alpha polypeptide |
| 713 | 1 | 12260 | C1QB | C1q deficiency, type B | 120570 | 4 | 1p36.3-p34.1 | complement component 1, q subcomponent, beta polypeptide |
| 715 | 5 | 50909 | C1R | C1r/C1s deficiency, combined | 216950 | 3 | 12p13 | complement component 1, r subcomponent |
| 718 | 3 | 12266 | C3 | C3 deficiency | 120700 | 2 | 19p13.3-p13.2 | complement component 3 |
| 720 | 1 | 20567 | C4A | C4 deficiency | 120810 | 9 | 6p21.3 | complement component 4A |
| 721 | 1 | 12268 | C4B | C4 deficiency | 120820 | 5 | 6p21.3 | complement component 4B |
| 727 | 3 | 15139 | C5 | C5 deficiency | 120900 | 3 | 9q32-q34 | complement component 5 |
| 729 | 2 | 12274 | C6 | C6 deficiency | 217050 | 5 | 5p13 | complement component 6 |
| 732 | 1 | 110382 | C8B | C8 deficiency, type II | 120960 | 3 | 1p32 | complement component 8, beta polypeptide |
| 760 | 10 | 12349 | CA2 | Renal tubular acidosis-osteopetrosis syndrome | 259730 | 6 | 8q22 | carbonic anhydrase II |
| 773 | 4 | 12286 | CACNA1A | Hemiplegic migraine, familial | 601011 | 18 | 19p13.2-p13.1 | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
| 778 | 2 | 54652 | CACNA1F | Night blindness, congenital stationary, X-linked, type 2 | 300110 | 5 | Xp11.23 | calcium channel, voltage-dependent, alpha 1F subunit |
| 779 | 3 | 12292 | CACNA1S | Malignant hyperthermia susceptibility 5 | 114208 | 6 | 1q32 | calcium channel, voltage-dependent, L type, alpha 1S subunit |
| 788 | 1 | 57279 | SLC25A20 | Carnitine-acylcarnitine translocase deficiency | 212138 | 3 | 3p21.31 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
| 799 | 3 | 12311 | CALCR | Osteoporosis, postmenopausal, susceptibility | 114131 | 8 | 7q21.3 | calcitonin receptor |
| 825 | 10 | 12335 | CAPN3 | Muscular dystrophy, limb-girdle, type 2A | 114240 | 5 | 15q15.1-q21.1 | calpain 3, (p94) |
| 846 | 7 | 12374 | CASR | Hypocalciuric hypercalcemia, type I | 601199 | 7 | 3q21-q24 | calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism) |
| 847 | 2 | 12359 | CAT | Acatalasemia | 115500 | 3 | 11p13 | catalase |
| 859 | 4 | 12391 | CAV3 | Muscular dystrophy, limb-girdle, type IC | 601253 | 7 | 3p25 | caveolin 3 |
| 860 | 2 | 12393 | RUNX2 | Dental anomalies, isolated | 600211 | 6 | 6p21 | runt-related transcription factor 2 |
| 861 | 1 | 12394 | RUNX1 | Platelet disorder, familial, with associated myeloid malignancy | 151385 | 11 | 21q22.3 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) |
| 865 | 1 | 12400 | CBFB | Myeloid leukemia, acute, M4Eo subtype | 121360 | 5 | 16q22.1 | core-binding factor, beta subunit |
| 866 | 10 | 12401 | SERPINA6 | Transcortin deficiency | 122500 | 2 | 14q32.1 | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
| 875 | 2 | 12411 | CBS | Thrombosis, hyperhomocysteinemic | 236200 | 10 | 21q22.3 | cystathionine-beta-synthase |
| 889 | 3 | 79264 | CCM1 | Cerebral cavernous malformations-1 | 604214 | 4 | 7q21-q22 | cerebral cavernous malformations 1 |
| 919 | 2 | 12503 | CD3Z | CD3, zeta chain, deficiency | 186780 | 3 | 1q22-q23 | CD3Z antigen, zeta polypeptide (TiT3 complex) |
| 920 | 1 | 12504 | CD4 | Lupus erythematosus, susceptibility to | 186940 | 3 | 12pter-p12 | CD4 antigen (p55) |
| 948 | 6 | 12491 | CD36 | Platelet glycoprotein IV deficiency | 173510 | 11 | 7q11.2 | CD36 antigen (collagen type I receptor, thrombospondin receptor) |
| 999 | 17 | 12550 | CDH1 | Ovarian carcinoma | 192090 | 13 | 16q22.1 | cadherin 1, type 1, E-cadherin (epithelial) |
| 1019 | 12 | 12567 | CDK4 | Melanoma | 123829 | 12 | 12q14 | cyclin-dependent kinase 4 |
| 1075 | 2 | 13032 | CTSC | Haim-Munk syndrome | 602365 | 3 | 11q14.1-q14.3 | cathepsin C |
| 1080 | 9 | 12638 | CFTR | Cystic fibrosis | 602421 | 8 | 7q31.2 | cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7) |
| 1121 | 2 | 12662 | CHM | Choroideremia | 300390 | 3 | Xq21.2 | choroideremia (Rab escort protein 1) |
| 1130 | 6 | 17101 | CHS1 | Chediak-Higashi syndrome | 606897 | 3 | 1q42.1-q42.2 | Chediak-Higashi syndrome 1 |
| 1134 | 18 | 11435 | CHRNA1 | Myasthenic syndrome, slow-channel congenital | 100690 | 3 | 2q24-q32 | cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) |
| 1137 | 18 | 11438 | CHRNA4 | Epilepsy, nocturnal frontal lobe, 1 | 118504 | 5 | 20q13.2-q13.3 | cholinergic receptor, nicotinic, alpha polypeptide 4 |
| 1139 | 15 | 11441 | CHRNA7 | Schizophrenia, neurophysiologic defect in | 118511 | 7 | 15q14 | cholinergic receptor, nicotinic, alpha polypeptide 7 |
| 1140 | 14 | 11443 | CHRNB1 | Myasthenic syndrome, slow-channel congenital | 100710 | 2 | 17p13.1 | cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
| 1145 | 16 | 11448 | CHRNE | Myasthenic syndrome, slow-channel congenital | 100725 | 2 | 17p13-p12 | cholinergic receptor, nicotinic, epsilon polypeptide |
| 1146 | 14 | 11449 | CHRNG | Myasthenia gravis, neonatal transient | 100730 | 3 | 2q33-q34 | cholinergic receptor, nicotinic, gamma polypeptide |
| 1161 | 5 | 71991 | CKN1 | Cockayne syndrome-1 | 216400 | 3 | 5q12.1 | Cockayne syndrome 1 (classical) |
| 1180 | 1 | 12723 | CLCN1 | Myotonia congenita, recessive | 118425 | 4 | 7q35 | chloride channel 1, skeletal muscle (Thomsen disease, autosomal dominant) |
| 1184 | 6 | 12728 | CLCN5 | Dent disease | 300008 | 2 | Xp11.23-p11.22 | chloride channel 5 (nephrolithiasis 2, X-linked, Dent disease) |
| 1188 | 1 | 56365 | CLCNKB | Bartter syndrome, antenatal | 602023 | 4 | 1p36 | chloride channel Kb |
| 1200 | 3 | 12751 | CLN2 | Ceroid-lipofuscinosis, neuronal 2, classic late infantile | 204500 | 4 | 11p15 | ceroid-lipofuscinosis, neuronal 2, late infantile (Jansky-Bielschowsky disease) |
| 1201 | 1 | 12752 | CLN3 | Ceroid-lipofuscinosis, neuronal-3, juvenile | 607042 | 17 | 16p12.1 | ceroid-lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
| 1231 | 16 | 12772 | CCR2 | HIV infection, susceptibility/resistence to | 601267 | 10 | 3p21 | chemokine (C-C motif) receptor 2 |
| 1234 | 12 | 12774 | CCR5 | HIV infection, susceptibility/resistance to | 601373 | 42 | 3p21 | chemokine (C-C motif) receptor 5 |
| 1244 | 11 | 12780 | ABCC2 | Dubin-Johnson syndrome | 601107 | 4 | 10q24 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
| 1259 | 1 | 12788 | CNGA1 | Retinitis pigmentosa, autosomal recessive | 123825 | 3 | 4p12-cen | cyclic nucleotide gated channel alpha 1 |
| 1277 | 11 | 12842 | COL1A1 | Osteogenesis imperfecta, type III | 120150 | 15 | 17q21.3-q22.1 | collagen, type I, alpha 1 |
| 1278 | 11 | 12843 | COL1A2 | Osteogenesis imperfecta, 3 clinical forms, 166200, 166210 | 120160 | 23 | 7q22.1 | collagen, type I, alpha 2 |
| 1280 | 11 | 12824 | COL2A1 | Epiphyseal dysplasia, multiple, with myopia and deafness | 120140 | 32 | 12q13.11-q13.2 | collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital) |
| 1281 | 11 | 12825 | COL3A1 | Ehlers-Danlos syndrome, type III | 120180 | 17 | 2q31 | collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) |
| 1285 | 2 | 12828 | COL4A3 | Alport syndrome, autosomal recessive | 120070 | 16 | 2q36-q37 | collagen, type IV, alpha 3 (Goodpasture antigen) |
| 1286 | 1 | 12829 | COL4A4 | Alport syndrome, autosomal recessive | 120131 | 5 | 2q35-q37 | collagen, type IV, alpha 4 |
| 1287 | 1 | 12830 | COL4A5 | Alport syndrome | 303630 | 11 | Xq22 | collagen, type IV, alpha 5 (Alport syndrome) |
| 1288 | 20 | 94216 | COL4A6 | Leiomyomatosis, diffuse, with Alport syndrome | 303631 | 14 | Xq22 | collagen, type IV, alpha 6 |
| 1289 | 2 | 12831 | COL5A1 | Ehlers-Danlos syndrome, type II | 120215 | 5 | 9q34.2-q34.3 | collagen, type V, alpha 1 |
| 1290 | 11 | 12832 | COL5A2 | Ehlers-Danlos syndrome, type I | 120190 | 9 | 2q14-q32 | collagen, type V, alpha 2 |
| 1291 | 2 | 12833 | COL6A1 | Bethlem myopathy | 120220 | 6 | 21q22.3 | collagen, type VI, alpha 1 |
| 1292 | 3 | 12834 | COL6A2 | Bethlem myopathy | 120240 | 15 | 21q22.3 | collagen, type VI, alpha 2 |
| 1293 | 3 | 12835 | COL6A3 | Bethlem myopathy | 120250 | 9 | 2q37 | collagen, type VI, alpha 3 |
| 1294 | 1 | 12836 | COL7A1 | Epidermolysis Epidermolysis bullosa dystrophica, AR | 120120 | 7 | 3p21.1 | collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) |
| 1299 | 2 | 12841 | COL9A3 | Intervertebral disc disease, susceptibility to | 120270 | 4 | 20q13.3 | collagen, type IX, alpha 3 |
| 1301 | 2 | 12814 | COL11A1 | Marshall syndrome | 120280 | 8 | 1p21 | collagen, type XI, alpha 1 |
| 1302 | 2 | 12815 | COL11A2 | OSMED syndrome | 601868 | 11 | 6p21.3 | collagen, type XI, alpha 2 |
| 1308 | 4 | 12821 | COL17A1 | Epidermolysis bullosa, generalized atrophic benign | 113811 | 6 | 10q24.3 | collagen, type XVII, alpha 1 |
| 1311 | 2 | 12845 | COMP | Pseudoachondroplasia | 600310 | 5 | 19p13.1 | cartilage oligomeric matrix protein (pseudoachondroplasia, epiphyseal dysplasia 1, multiple) |
| 1356 | 8 | 12870 | CP | Hemosiderosis, systemic, due to aceruloplasminemia | 117700 | 5 | 3q23-q25 | ceruloplasmin (ferroxidase) |
| 1361 | 7 | 56373 | CPB2 | 603101 | 5 | 13q14.11 | carboxypeptidase B2 (plasma, carboxypeptidase U) | |
| 1373 | 1 | 107486 | CPS1 | Carbamoylphosphate synthetase I deficiency | 237300 | 3 | 2q35 | carbamoyl-phosphate synthetase 1, mitochondrial |
| 1374 | 10 | 12894 | CPT1A | CPT deficiency, hepatic, type I | 600528 | 3 | 11q13.1-q13.2 | carnitine palmitoyltransferase I, liver |
| 1376 | 5 | 12896 | CPT2 | Myopathy due to CPT II deficiency | 600650 | 6 | 1p32 | carnitine palmitoyltransferase II |
| 1378 | 2 | 12946 | CR1 | ?SLE susceptibility | 120620 | 17 | 1q32 | complement component (3b/4b) receptor 1, including Knops blood group system |
| 1387 | 2 | 12914 | CREBBP | Rubenstein-Taybi syndrome | 600140 | 3 | 16p13.3 | CREB binding protein (Rubinstein-Taybi syndrome) |
| 1406 | 1 | 12951 | CRX | Retinitis pigmentosa, late-onset dominant | 602225 | 3 | 19q13.3 | cone-rod homeobox |
| 1415 | 3 | 12961 | CRYBB2 | Cataract, cerulean, type 2 | 123620 | 3 | 22q11.23 | crystallin, beta B2 |
| 1418 | 2 | 12964 | CRYGA | 123660 | 2 | 2q33-q35 | crystallin, gamma A | |
| 1421 | 2 | 12967 | CRYGD | Cataracts, punctate, progressive juvenile-onset | 123690 | 4 | 2q33-q35 | crystallin, gamma D |
| 1436 | 12 | 12978 | CSF1R | Myeloid malignancy, predisposition to | 164770 | 3 | 5q33-q35 | colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog |
| 1441 | 1 | 12986 | CSF3R | 138971 | 6 | 1p35-p34.3 | colony stimulating factor 3 receptor (granulocyte) | |
| 1442 | 7 | 18775 | CSH1 | Placental lactogen deficiency | 150200 | 13 | 17q24.2 | chorionic somatomammotropin hormone 1 (placental lactogen) |
| 1491 | 1 | 70338 | CTH | Cystathioninuria | 219500 | 3 | 1p31.1 | cystathionase (cystathionine gamma-lyase) |
| 1497 | 4 | 83429 | CTNS | Cystinosis, late-onset juvenile or adolescent nephropathic | 606272 | 3 | 17p13 | cystinosis, nephropathic |
| 1499 | 3 | 12387 | CTNNB1 | Colorectal cancer | 116806 | 3 | 3p21 | catenin (cadherin-associated protein), beta 1 (88kDa |
| 1513 | 17 | 13038 | CTSK | Pycnodysostosis | 601105 | 6 | 1q21 | cathepsin K (pycnodysostosis) |
| 1535 | 3 | 13057 | CYBA | Chronic granulomatous disease, autosomal, due to deficiency of CYBA | 233690 | 3 | 16q24 | cytochrome b-245, alpha polypeptide |
| 1536 | 4 | 13058 | CYBB | Chronic granulomatous disease, X-linked | 306400 | 4 | Xp21.1 | cytochrome b-245, beta polypeptide (chronic granulomatous disease) |
| 1545 | 19 | 13078 | CYP1B1 | Peters anomaly | 601771 | 4 | 2p21 | cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile) |
| 1548 | 25 | 13087 | CYP2A6 | Coumarin resistance | 122720 | 9 | 19q13.2 | cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 6 |
| 1557 | 25 | 13095 | CYP2C19 | Mephenytoin poor metabolizer | 124020 | 3 | 10q24.1-q24.3 | cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 19 |
| 1581 | 7 | 13122 | CYP7A1 | 118455 | 5 | 8q11-q12 | cytochrome P450, subfamily VIIA (cholesterol 7 alpha-monooxygenase), polypeptide 1 | |
| 1583 | 2 | 13070 | CYP11A | 118485 | 6 | 15q23-q24 | cytochrome P450, subfamily XIA (cholesterol side chain cleavage) | |
| 1586 | 4 | 13074 | CYP17 | Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency | 202110 | 5 | 10q24.3 | cytochrome P450, subfamily XVII (steroid 17-alpha-hydroxylase), adrenal hyperplasia |
| 1593 | 1 | 104086 | CYP27A1 | Cerebrotendinous xanthomatosis | 606530 | 5 | 2q33-qter | cytochrome P450, subfamily XXVIIA (steroid 27-hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1 |
| 1594 | 1 | 13115 | CYP27B1 | Pseudovitamin D deficiency rickets 1 | 264700 | 10 | 12q13.1-q13.3 | cytochrome P450, subfamily XXVIIB (25-hydroxyvitamin D-1-alpha-hydroxylase), polypeptide 1 |
| 1621 | 3 | 13166 | DBH | Dopamine-beta-hydroxylase activity levels, plasma | 223360 | 6 | 9q34 | dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
| 1629 | 1 | 13171 | DBT | Maple syrup urine disease, type II | 248610 | 6 | 1p31 | dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex; maple syrup urine disease) |
| 1630 | 7 | 13176 | DCC | Colorectal cancer | 120470 | 3 | 18q21.3 | deleted in colorectal carcinoma |
| 1641 | 7 | 13193 | DCX | Subcortical laminal heteropia, X-linked | 300121 | 3 | Xq22.3-q23 | doublecortex; lissencephaly, X-linked (doublecortin) |
| 1674 | 8 | 13346 | DES | Myopathy, desmin-related, cardioskeletal | 125660 | 11 | 2q35 | desmin |
| 1687 | 2 | 54722 | DFNA5 | Deafness, autosomal dominant 5 | 600994 | 7 | 7p15 | deafness, autosomal dominant 5 |
| 1690 | 3 | 12810 | COCH | Meniere disease | 603196 | 3 | 14q12-q13 | coagulation factor C homolog, cochlin (Limulus polyphemus) |
| 1717 | 3 | 13360 | DHCR7 | Smith-Lemli-Opitz syndrome, type II | 602858 | 4 | 11q13.2-q13.5 | 7-dehydrocholesterol reductase |
| 1727 | 5 | 109754 | DIA1 | Methemoglobinemia, type II | 250800 | 11 | 22q13.2-q13.31 | diaphorase (NADH) (cytochrome b-5 reductase) |
| 1729 | 3 | 13367 | DIAPH1 | Deafness, autosomal dominant 1 | 602121 | 3 | 5q31 | diaphanous homolog 1 (Drosophila) |
| 1738 | 2 | 13382 | DLD | Lipoamide dehydrogenase deficiency | 246900 | 4 | 7q31-q32 | dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex) |
| 1755 | 14 | 12945 | DMBT1 | Medulloblastoma | 601969 | 9 | 10q25.3-q26.1 | deleted in malignant brain tumors 1 |
| 1756 | 11 | 13405 | DMD | Cardiomyopathy, dilated, X-linked | 300377 | 52 | Xp21.2 | dystrophin (muscular dystrophy, Duchenne and Becker types) |
| 1760 | 1 | 13400 | DMPK | Myotonic dystrophy | 605377 | 14 | 19q13.3 | dystrophia myotonica-protein kinase |
| 1807 | 5 | 64705 | DPYS | Dihydropyrimidinuria | 222748 | 3 | 8q22 | dihydropyrimidinase |
| 1814 | 2 | 13490 | DRD3 | ?Schizophrenia, susceptibility to | 126451 | 12 | 3q13.3 | dopamine receptor D3 |
| 1815 | 2 | 13491 | DRD4 | Autonomic nervous system dysfunction | 126452 | 6 | 11p15.5 | dopamine receptor D4 |
| 1836 | 10 | 13521 | SLC26A2 | Epiphyseal dysplasia, multiple | 606718 | 2 | 5q31-q34 | solute carrier family 26 (sulfate transporter), member 2 |
| 1861 | 11 | 30931 | DYT1 | Dystonia, early-onset atypical, with myoclonic features | 605204 | 4 | 9q34 | dystonia 1, torsion (autosomal dominant; torsin A) |
| 1890 | 1 | 18592 | ECGF1 | Myoneurogastrointestinal encephalomyopathy syndrome | 131222 | 4 | 22q13.33 | endothelial cell growth factor 1 (platelet-derived) |
| 1908 | 3 | 13616 | EDN3 | Shah-Waardenburg syndrome | 131242 | 5 | 20q13.2-q13.3 | endothelin 3 |
| 1910 | 8 | 13618 | EDNRB | ABCD syndrome | 131244 | 8 | 13q22 | endothelin receptor type B |
| 1959 | 3 | 13654 | EGR2 | Charcot-Marie-Tooth disease, type 1 | 129010 | 4 | 10q21.1 | early growth response 2 (Krox-20 homolog, Drosophila) |
| 1962 | 2 | 74147 | EHHADH | Peroxisomal bifunctional enzyme deficiency | 607037 | 2 | 3q26.3-q28 | enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
| 1996 | 10 | 15572 | ELAVL4 | Neuropathy, paraneoplastic sensory | 168360 | 3 | 1p34 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) |
| 2023 | 7 | 13806 | ENO1 | Enolase deficiency | 172430 | 13 | 1p36.3-p36.2 | enolase 1, (alpha) |
| 2035 | 21 | 13820 | EPB41 | Elliptocytosis-1 | 130500 | 6 | 1p33-p32 | erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
| 2038 | 13 | 13828 | EPB42 | Spherocytosis, hereditary, Japanese type | 177070 | 7 | 15q15-q21 | erythrocyte membrane protein band 4.2 |
| 2055 | 4 | 26889 | CLN8 | Epilepsy, progressive, with mental retardation | 600143 | 7 | 8p23 | ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
| 2057 | 1 | 13857 | EPOR | Erythrocytosis, familial | 133171 | 8 | 19p13.3-p13.2 | erythropoietin receptor |
| 2068 | 3 | 13871 | ERCC2 | Trichothiodystrophy | 126340 | 5 | 19q13.3 | excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) |
| 2070 | 2 | 14051 | EYA4 | Deafness, autosomal dominant 10 | 603550 | 2 | 6q23 | eyes absent homolog 4 (Drosophila) |
| 2071 | 1 | 13872 | ERCC3 | Trichothiodystrophy | 133510 | 3 | 2q21 | excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) |
| 2072 | 2 | 50505 | ERCC4 | Xeroderma pigmentosum, group F | 133520 | 3 | 16p13.3-p13.11 | excision repair cross-complementing rodent repair deficiency, complementation group 4 |
| 2073 | 1 | 22592 | ERCC5 | Cerebrooculofacioskeletal syndrome | 133530 | 5 | 13q22 | excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) |
| 2074 | 19 | 108149 | ERCC6 | De Sanctis-Cacchione syndrome | 133540 | 2 | 10q11 | excision repair cross-complementing rodent repair deficiency, complementation group 6 |
| 2099 | 13 | 13982 | ESR1 | Estrogen resistance | 133430 | 5 | 6q25.1 | estrogen receptor 1 |
| 2108 | 2 | 110842 | ETFA | Glutaricaciduria, type IIA | 231680 | 4 | 15q23-q25 | electron-transfer-flavoprotein, alpha polypeptide (glutaric aciduria II) |
| 2109 | 2 | 110826 | ETFB | Glutaricaciduria, type IIB | 130410 | 2 | 19q13.3 | electron-transfer-flavoprotein, beta polypeptide |
| 2110 | 5 | 110807 | ETFDH | Glutaricaciduria, type IIC | 231675 | 2 | 4q32-q35 | electron-transferring-flavoprotein dehydrogenase |
| 2120 | 27 | 14011 | ETV6 | Leukemia, acute lymphoblastic | 600618 | 7 | 12p13 | ets variant gene 6 (TEL oncogene) |
| 2121 | 2 | 59056 | EVC | Weyers acrodental dysostosis | 604831 | 5 | 4p16 | Ellis van Creveld syndrome |
| 2131 | 2 | 14042 | EXT1 | Chondrosarcoma | 133700 | 4 | 8q24.11-q24.13 | exostoses (multiple) 1 |
| 2132 | 3 | 14043 | EXT2 | Exostoses, multiple, type 2 | 133701 | 6 | 11p12-p11 | exostoses (multiple) 2 |
| 2138 | 2 | 14048 | EYA1 | Branchiootorenal syndrome with cataract | 601653 | 4 | 8q13.3 | eyes absent homolog 1 (Drosophila) |
| 2153 | 11 | 14067 | F5 | Thromboembolism susceptibility due to factor V Leiden | 227400 | 6 | 1q23 | coagulation factor V (proaccelerin, labile factor) |
| 2155 | 1 | 14068 | F7 | Myocardial infarction, decreased susceptibility to | 227500 | 6 | 13q34 | coagulation factor VII (serum prothrombin conversion accelerator) |
| 2157 | 11 | 14069 | F8 | Hemophilia A | 306700 | 10 | Xq28 | coagulation factor VIII, procoagulant component (hemophilia A) |
| 2158 | 1 | 14071 | F9 | Warfarin sensitivity | 306900 | 10 | Xq27.1-q27.2 | coagulation factor IX (plasma thromboplastic component, Christmas disease, hemophilia B) |
| 2160 | 5 | 109821 | F11 | Factor XI deficiency | 264900 | 6 | 4q35 | coagulation factor XI (plasma thromboplastin antecedent) |
| 2161 | 2 | 58992 | F12 | Factor XII deficiency | 234000 | 11 | 5q33-qter | coagulation factor XII (Hageman factor) |
| 2165 | 1 | 14060 | F13B | Factor XIIIB deficiency | 134580 | 4 | 1q31-q32.1 | coagulation factor XIII, B polypeptide |
| 2175 | 2 | 14087 | FANCA | Fanconi anemia, complementation group A | 603468 | 6 | 16q24.3 | Fanconi anemia, complementation group A |
| 2176 | 3 | 14088 | FANCC | Fanconi anemia, complementation group C | 227645 | 4 | 9q22.3 | Fanconi anemia, complementation group C |
| 2200 | 15 | 14118 | FBN1 | Marfan syndrome | 134797 | 3 | 15q21.1 | fibrillin 1 (Marfan syndrome) |
| 2201 | 15 | 14119 | FBN2 | Contractural arachnodactyly, congenital | 121050 | 2 | 5q23-q31 | fibrillin 2 (congenital contractural arachnodactyly) |
| 2203 | 1 | 14121 | FBP1 | Fructose-bisphosphatase deficiency | 229700 | 11 | 9q22.3 | fructose-1,6-bisphosphatase 1 |
| 2209 | 1 | 14129 | FCGR1A | IgG receptor I, phagocytic, familial deficiency of | 146760 | 4 | 1q21.2-q21.3 | Fc fragment of IgG, high affinity Ia, receptor for (CD64) |
| 2212 | 3 | 14130 | FCGR2A | Lupus nephritis, susceptibility to | 146790 | 3 | 1q23 | Fc fragment of IgG, low affinity IIa, receptor for (CD32) |
| 2213 | 3 | 14130 | FCGR2B | Lymphoma, progression of | 604590 | 3 | 1q23 | Fc fragment of IgG, low affinity IIb, receptor for (CD32) |
| 2214 | 3 | 14131 | FCGR3A | Lupus erythematosus, systemic, susceptibility | 146740 | 7 | 1q23 | Fc fragment of IgG, low affinity IIIa, receptor for (CD16) |
| 2218 | 2 | 230193 | FCMD | Muscular dystrophy, Fukuyama congenital | 253800 | 3 | 9q31-q33 | Fukuyama type congenital muscular dystrophy (fukutin) |
| 2235 | 3 | 14151 | FECH | Protoporphyria, erythropoietic, recessive, with liver failure | 177000 | 3 | 18q21.3 | ferrochelatase (protoporphyria) |
| 2244 | 2 | 110135 | FGB | Thrombophilia, dysfibrinogenemic | 134830 | 6 | 4q28 | fibrinogen, B beta polypeptide |
| 2245 | 8 | 14163 | FGD1 | Aarskog-Scott syndrome | 305400 | 2 | Xp11.21 | faciogenital dysplasia (Aarskog-Scott syndrome) |
| 2260 | 25 | 14182 | FGFR1 | Pfeiffer syndrome | 136350 | 29 | 8p11.2-p11.1 | fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) |
| 2261 | 22 | 14184 | FGFR3 | Colorectal cancer, somatic | 134934 | 10 | 4p16.3 | fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) |
| 2263 | 21 | 14183 | FGFR2 | Craniosynostosis, nonspecific | 176943 | 32 | 10q26 | fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) |
| 2266 | 2 | 14188 | FGG | Thrombophilia, dysfibrinogenemic | 134850 | 11 | 4q28 | fibrinogen, gamma polypeptide |
| 2271 | 1 | 14194 | FH | Multiple cutaneous and uterine leiomyomata, | 136850 | 6 | 1q42.1 | fumarate hydratase |
| 2296 | 1 | 17300 | FOXC1 | Iridogoniodysgenesis | 601090 | 5 | 6p25 | forkhead box C1 |
| 2308 | 3 | 56458 | FOXO1A | Rhabdomyosarcoma, alveolar | 136533 | 4 | 13q14.1 | forkhead box O1A (rhabdomyosarcoma) |
| 2316 | 6 | 14249 | FLNA | Heterotopia, periventricular | 300017 | 4 | Xq28 | filamin A, alpha (actin binding protein 280) |
| 2324 | 13 | 14257 | FLT4 | Hemangioma, capillary infantile, somatic | 136352 | 3 | 5q34-q35 | fms-related tyrosine kinase 4 |
| 2328 | 2 | 14262 | FMO3 | Fish-odor syndrome | 136132 | 5 | 1q23-q25 | flavin containing monooxygenase 3 |
| 2332 | 5 | 14265 | FMR1 | Fragile X syndrome | 309550 | 10 | Xq27.3 | fragile X mental retardation 1 |
| 2492 | 5 | 14309 | FSHR | Twinning, dizygotic | 136435 | 3 | 2p21-p16 | follicle stimulating hormone receptor |
| 2512 | 8 | 14325 | FTL | Basal ganglia disease, adult-onset | 134790 | 7 | 19q13.3-q13.4 | ferritin, light polypeptide |
| 2517 | 10 | 109714 | FUCA1 | Fucosidosis | 230000 | 4 | 1p34 | fucosidase, alpha-L- 1, tissue |
| 2531 | 1 | 70750 | FVT1 | Lymphoma/leukemia, B-cell, variant | 136440 | 3 | 18q21.3 | follicular lymphoma variant translocation 1 |
| 2538 | 3 | 14377 | G6PC | Glycogen storage disease I | 232200 | 3 | 17q21 | glucose-6-phosphatase, catalytic (glycogen storage disease type I, von Gierke disease) |
| 2539 | 4 | 14381 | G6PD | G6PD deficiency | 305900 | 12 | Xq28 | glucose-6-phosphate dehydrogenase |
| 2542 | 1 | 14385 | G6PT1 | Glycogen storage disease Ic | 602671 | 9 | 11q23.3 | glucose-6-phosphatase, transport (glucose-6-phosphate) protein 1 |
| 2548 | 9 | 14387 | GAA | Glycogen storage disease II | 606800 | 5 | 17q25.2-q25.3 | glucosidase, alpha; acid (Pompe disease, glycogen storage disease type II) |
| 2581 | 2 | 14420 | GALC | Krabbe disease | 606890 | 6 | 14q31 | galactosylceramidase (Krabbe disease) |
| 2582 | 1 | 74246 | GALE | Galactose epimerase deficiency | 606953 | 5 | 1p36-p35 | galactose-4-epimerase, UDP- |
| 2584 | 4 | 14635 | GALK1 | Galactokinase deficiency with cataracts | 604313 | 5 | 17q24 | galactokinase 1 |
| 2588 | 4 | 50917 | GALNS | Mucopolysaccharidosis IVA | 253000 | 3 | 16q24.3 | galactosamine (N-acetyl)-6-sulfate sulfatase (Morquio syndrome, mucopolysaccharidosis type IVA) |
| 2592 | 1 | 14430 | GALT | Galactosemia | 606999 | 21 | 9p13 | galactose-1-phosphate uridylyltransferase |
| 2629 | 1 | 14466 | GBA | Gaucher disease | 606463 | 7 | 1q21 | glucosidase, beta; acid (includes glucosylceramidase) |
| 2632 | 3 | 74185 | GBE1 | Glycogen storage disease IV | 232500 | 2 | 3p12.3 | glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) |
| 2639 | 2 | 14488 | GCDH | Glutaricaciduria, type I | 231670 | 7 | 19p13.2 | glutaryl-Coenzyme A dehydrogenase |
| 2641 | 1 | 14526 | GCG | ?Hyperproglucagonemia | 138030 | 5 | 2q36-q37 | glucagon |
| 2642 | 9 | 14527 | GCGR | Diabetes mellitus, noninsulin-dependent | 138033 | 3 | 17q25 | glucagon receptor |
| 2651 | 6 | 14538 | GCNT2 | Ii blood group | 600429 | 4 | 6p24 | glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
| 2652 | 2 | 14539 | OPN1MW | Colorblindness, deutan | 303800 | 2 | Xq28 | opsin 1 (cone pigments), medium-wave-sensitive (color blindness, deutan) |
| 2664 | 12 | 14567 | GDI1 | Mental retardation, X-linked nonspecific | 300104 | 7 | Xq28 | GDP dissociation inhibitor 1 |
| 2678 | 4 | 14598 | GGT1 | Glutathioninuria | 231950 | 20 | 22q11.23 | gamma-glutamyltransferase 1 |
| 2679 | 1 | 110088 | GGT2 | Gamma-glutamyltransferase, familial high serum | 137181 | 2 | 22q11.23 | gamma-glutamyltransferase 2 |
| 2688 | 7 | 14599 | GH1 | Isolated growth hormone deficiency, Illig type with absent GH and Kowarski type with bioinactive GH | 139250 | 13 | 17q24.2 | growth hormone 1 |
| 2692 | 9 | 14602 | GHRHR | Growth hormone deficient dwarfism | 139191 | 9 | 7p14 | growth hormone releasing hormone receptor |
| 2694 | 1 | 14603 | GIF | Anemia, pernicious, congenital, due to deficiency of intrinsic factor | 261000 | 3 | 11q13 | gastric intrinsic factor (vitamin B synthesis) |
| 2700 | 4 | 14611 | GJA3 | Cataract, zonular pulverulent-3 | 121015 | 3 | 13q11-q12 | gap junction protein, alpha 3, 46kDa (connexin 46) |
| 2703 | 4 | 14616 | GJA8 | Cataract, zonular pulverulent-1 | 600897 | 2 | 1q21.1 | gap junction protein, alpha 8, 50kDa (connexin 50) |
| 2705 | 6 | 14618 | GJB1 | Charcot-Marie-Tooth neuropathy, X-linked-1, dominant | 304040 | 4 | Xq13.1 | gap junction protein, beta 1, 32kDa (connexin 32, Charcot-Marie-Tooth neuropathy, X-linked) |
| 2706 | 8 | 14619 | GJB2 | Vohwinkel syndrome | 121011 | 5 | 13q11-q12 | gap junction protein, beta 2, 26kDa (connexin 26) |
| 2707 | 3 | 14620 | GJB3 | Deafness, autosomal dominant, with peripheral neuropathy | 603324 | 6 | 1p34 | gap junction protein, beta 3, 31kDa (connexin 31) |
| 2710 | 7 | 14933 | GK | Hyperglycerolemia | 307030 | 5 | Xp21.3 | glycerol kinase |
| 2717 | 3 | 11605 | GLA | Fabry disease | 301500 | 7 | Xq22 | galactosidase, alpha |
| 2719 | 3 | 14734 | GPC3 | Simpson-Golabi-Behmel syndrome, type 1 | 300037 | 7 | Xq26.1 | glypican 3 |
| 2720 | 9 | 12091 | GLB1 | GM1-gangliosidosis | 230500 | 6 | 3p21.33 | galactosidase, beta 1 |
| 2731 | 5 | 104174 | GLDC | Glycine encephalopathy | 238300 | 4 | 9p22 | glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) |
| 2737 | 1 | 14634 | GLI3 | Polydactyly, postaxial, types A1 and B | 165240 | 3 | 7p13 | GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome) |
| 2741 | 28 | 14654 | GLRA1 | Startle disease/hyperekplexia, autosomal dominant | 138491 | 3 | 5q32 | glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man syndrome) |
| 2746 | 2 | 14661 | GLUD1 | Hyperinsulinism-hyperammonemia syndrome | 138130 | 6 | 10q23.3 | glutamate dehydrogenase 1 |
| 2771 | 10 | 14678 | GNAI2 | Ventricular tachycardia, idiopathic | 139360 | 4 | 3p21 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
| 2776 | 10 | 14682 | GNAQ | Bleeding diathesis due to GNAQ deficiency | 600998 | 3 | 9q21 | guanine nucleotide binding protein (G protein), q polypeptide |
| 2778 | 12 | 14683 | GNAS | Osseous heteroplasia, progressive | 139320 | 26 | 20q13.2-q13.3 | GNAS complex locus |
| 2779 | 10 | 14685 | GNAT1 | Night blindness, congenital stationary | 139330 | 2 | 3p21 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
| 2784 | 5 | 14695 | GNB3 | Hypertension, essential, susceptibility to | 139130 | 10 | 12p13 | guanine nucleotide binding protein (G protein), beta polypeptide 3 |
| 2820 | 1 | 14571 | GPD2 | Diabetes mellitus, noninsulin-dependent | 138430 | 4 | 2q24.1 | glycerol-3-phosphate dehydrogenase 2 (mitochondrial) |
| 2821 | 2 | 14751 | GPI | Hemolytic anemia due to glucosephosphate isomerase deficiency | 172400 | 4 | 19q13.1 | glucose phosphate isomerase |
| 2876 | 4 | 14775 | GPX1 | Hemolytic anemia due to glutathione peroxidase deficiency | 138320 | 4 | 3p21.3 | glutathione peroxidase 1 |
| 2887 | 4 | 14783 | GRB10 | 601523 | 9 | 7p12-p11.2 | growth factor receptor-bound protein 10 | |
| 2908 | 2 | 14815 | NR3C1 | Cortisol resistance | 138040 | 10 | 5q31 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 2934 | 4 | 14851 | GSN | Amyloidosis, Finnish type | 137350 | 3 | 9q33 | gelsolin (amyloidosis, Finnish type) |
| 2936 | 7 | 14782 | GSR | Hemolytic anemia due to glutathione reductase deficiency | 138300 | 3 | 8p21.1 | glutathione reductase |
| 2937 | 1 | 14854 | GSS | 5-oxoprolinuria | 601002 | 4 | 20q11.2 | glutathione synthetase |
| 2956 | 2 | 17688 | MSH6 | Colorectal cancer, hereditary nonpolyposis, type 5 | 600678 | 5 | 2p16 | mutS homolog 6 (E. coli) |
| 2990 | 2 | 14927 | GUSB | Mucopolysaccharidosis VII | 253220 | 2 | 7q21.11 | glucuronidase, beta |
| 2997 | 2 | 14936 | GYS1 | Diabetes mellitus, noninsulin-dependent | 138570 | 5 | 19q13.3 | glycogen synthase 1 (muscle) |
| 3029 | 4 | 14651 | HAGH | Glyoxalase II deficiency | 138760 | 5 | 16p13.3 | hydroxyacyl glutathione hydrolase |
| 3034 | 4 | 15109 | HAL | Histidinemia | 235800 | 2 | 12q22-q24.1 | histidine ammonia-lyase |
| 3040 | 27 | 15122 | HBA2 | Hemoglobin H disease | 141850 | 12 | 16p13.3 | hemoglobin, alpha 2 |
| 3043 | 48 | 15127 | HBB | Thalassemias, beta- | 141900 | 42 | 11p15.5 | hemoglobin, beta |
| 3045 | 47 | 15129 | HBD | Thalassemia, delta- | 142000 | 3 | 11p15.5 | hemoglobin, delta |
| 3047 | 46 | 15132 | HBG1 | HPFH, nondeletion type A | 142200 | 13 | 11p15.5 | hemoglobin, gamma A |
| 3064 | 2 | 15194 | HD | Huntington disease | 143100 | 5 | 4p16.3 | huntingtin (Huntington disease) |
| 3073 | 5 | 15211 | HEXA | GM2-gangliosidosis, several forms | 606869 | 5 | 15q23-q24 | hexosaminidase A (alpha polypeptide) |
| 3074 | 5 | 15212 | HEXB | Sandhoff disease, infantile, juvenile, and adult forms | 606873 | 6 | 5q13 | hexosaminidase B (beta polypeptide) |
| 3075 | 4 | 12628 | HF1 | Factor H deficiency | 134370 | 4 | 1q32 | H factor 1 (complement) |
| 3077 | 2 | 15216 | HFE | Porphyria variegata | 235200 | 22 | 6p21.3 | hemochromatosis |
| 3081 | 2 | 15233 | HGD | Alkaptonuria | 203500 | 5 | 3q21-q23 | homogentisate 1,2-dioxygenase (homogentisate oxidase) |
| 3141 | 1 | 110948 | HLCS | Multiple carboxylase deficiency, biotin-responsive | 253270 | 3 | 21q22.13 | holocarboxylase synthetase (biotin-[proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) |
| 3145 | 1 | 15288 | HMBS | Porphyria, acute intermittent, nonerythroid variant | 176000 | 6 | 11q23.3 | hydroxymethylbilane synthase |
| 3155 | 1 | 15356 | HMGCL | HMG-CoA lyase deficiency | 246450 | 4 | 1p36.1-p35 | 3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria) |
| 3158 | 7 | 15360 | HMGCS2 | HMG-CoA synthase-2 deficiency | 600234 | 5 | 1p13-p12 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) |
| 3209 | 1 | 15398 | HOXA13 | Guttmacher syndrome | 142959 | 2 | 7p15-p14 | homeo box A13 |
| 3239 | 1 | 15433 | HOXD13 | Synpolydactyly, type II | 142989 | 2 | 2q31 | homeo box D13 |
| 3251 | 3 | 15452 | HPRT1 | Lesch-Nyhan syndrome | 308000 | 5 | Xq26.1 | hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) |
| 3257 | 2 | 192236 | HPS1 | Hermansky-Pudlak syndrome | 604982 | 5 | 10q23.1-q23.3 | Hermansky-Pudlak syndrome 1 |
| 3265 | 2 | 15461 | HRAS | Bladder cancer | 190020 | 3 | 11p15.5 | v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
| 3284 | 1 | 15492 | HSD3B2 | 3-beta-hydroxysteroid dehydrogenase, type II, deficiency | 201810 | 3 | 1p13.1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
| 3293 | 4 | 15487 | HSD17B3 | Pseudohermaphroditism, male, with gynecomastia | 605573 | 2 | 9q22 | hydroxysteroid (17-beta) dehydrogenase 3 |
| 3295 | 2 | 15488 | HSD17B4 | D-bifunctional protein deficiency | 601860 | 4 | 5q21 | hydroxysteroid (17-beta) dehydrogenase 4 |
| 3373 | 9 | 15586 | HYAL1 | Mucopolysaccharidosis type IX | 607071 | 8 | 3p21.3-p21.2 | hyaluronoglucosaminidase 1 |
| 3423 | 1 | 15931 | IDS | Mucopolysaccharidosis II | 309900 | 10 | Xq28 | iduronate 2-sulfatase (Hunter syndrome) |
| 3425 | 2 | 15932 | IDUA | Mucopolysaccharidosis Ih/s | 252800 | 3 | 4p16.3 | iduronidase, alpha-L- |
| 3459 | 1 | 15979 | IFNGR1 | Mycobacterial infection, atypical, familial disseminated | 107470 | 4 | 6q23-q24 | interferon gamma receptor 1 |
| 3479 | 2 | 16000 | IGF1 | Growth retardation with deafness and mental retardation | 147440 | 17 | 12q22-q23 | insulin-like growth factor 1 (somatomedin C) |
| 3482 | 2 | 16004 | IGF2R | Hepatocellular carcinoma | 147280 | 5 | 6q26 | insulin-like growth factor 2 receptor |
| 3507 | 5 | 16019 | IGHM | Agammaglobulinemia | 147020 | 4 | 14q32.33 | immunoglobulin heavy constant mu |
| 3514 | 1 | 16071 | IGKC | Kappa light chain deficiency | 147200 | 3 | 2p12 | immunoglobulin kappa constant |
| 3559 | 2 | 16184 | IL2RA | Interleukin-2 receptor, alpha chain, deficiency of | 147730 | 7 | 10p15-p14 | interleukin 2 receptor, alpha |
| 3566 | 3 | 16190 | IL4R | Atopy, susceptibility to | 147781 | 3 | 16p11.2-12.1 | interleukin 4 receptor |
| 3575 | 4 | 16197 | IL7R | Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type | 146661 | 2 | 5p13 | interleukin 7 receptor |
| 3643 | 23 | 16337 | INSR | Leprechaunism | 147670 | 8 | 19p13.3-p13.2 | insulin receptor |
| 3651 | 1 | 18609 | IPF1 | Pancreatic agenesis | 600733 | 5 | 13q12.1 | insulin promoter factor 1, homeodomain transcription factor |
| 3655 | 6 | 16403 | ITGA6 | Epidermolysis bullosa, junctional, with pyloric stenosis | 147556 | 6 | 2q31.1 | integrin, alpha 6 |
| 3667 | 1 | 16367 | IRS1 | Diabetes mellitus, noninsulin-dependent | 147545 | 2 | 2q36 | insulin receptor substrate 1 |
| 3673 | 7 | 16398 | ITGA2 | Neonatal alloimmune thrombocytopenia | 192974 | 4 | 5q23-q31 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
| 3674 | 2 | 16399 | ITGA2B | Thrombocytopenia, neonatal alloimmune | 273800 | 11 | 17q21.32 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B) |
| 3679 | 4 | 16404 | ITGA7 | Myopathy, congenital | 600536 | 7 | 12q13 | integrin, alpha 7 |
| 3689 | 13 | 16414 | ITGB2 | Leukocyte adhesion deficiency | 600065 | 5 | 21q22.3 | integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit) |
| 3690 | 15 | 16416 | ITGB3 | Glanzmann thrombasthenia, type B | 173470 | 12 | 17q21.32 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
| 3691 | 11 | 16417 | ITGB4 | Epidermolysis bullosa, junctional, with pyloric atresia | 147557 | 6 | 17q11-qter | integrin, beta 4 |
| 3704 | 2 | 16434 | ITPA | Inosine triphosphatase deficiency | 147520 | 5 | 20p | inosine triphosphatase (nucleoside triphosphate pyrophosphatase) |
| 3712 | 15 | 56357 | IVD | Isovalericacidemia | 243500 | 5 | 15q14-q15 | isovaleryl Coenzyme A dehydrogenase |
| 3718 | 3 | 16453 | JAK3 | SCID, autosomal recessive, T-negative/B-positive type | 600173 | 7 | 19p13.1 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) |
| 3736 | 6 | 16485 | KCNA1 | Episodic ataxia/myokymia syndrome | 176260 | 2 | 12p13 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) |
| 3753 | 2 | 16509 | KCNE1 | Long QT syndrome-5 | 176261 | 4 | 21q22.12 | potassium voltage-gated channel, Isk-related family, member 1 |
| 3757 | 5 | 16511 | KCNH2 | Long QT syndrome-2 | 152427 | 5 | 7q35-q36 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
| 3758 | 22 | 56379 | KCNJ1 | Bartter syndrome, antenatal | 600359 | 8 | 11q24 | potassium inwardly-rectifying channel, subfamily J, member 1 |
| 3767 | 22 | 16514 | KCNJ11 | Persistent hyperinsulinemic hypoglycemia of infancy | 600937 | 2 | 11p15.1 | potassium inwardly-rectifying channel, subfamily J, member 11 |
| 3784 | 1 | 16535 | KCNQ1 | Long QT syndrome-1 | 192500 | 4 | 11p15.5 | potassium voltage-gated channel, KQT-like subfamily, member 1 |
| 3785 | 3 | 16536 | KCNQ2 | Myokymia with neonatal epilepsy | 602235 | 5 | 20q13.3 | potassium voltage-gated channel, KQT-like subfamily, member 2 |
| 3786 | 1 | 110862 | KCNQ3 | Epilepsy, benign neonatal, type 2 | 602232 | 3 | 8q24 | potassium voltage-gated channel, KQT-like subfamily, member 3 |
| 3795 | 3 | 16548 | KHK | Fructosuria | 229800 | 8 | 2p23.3-p23.2 | ketohexokinase (fructokinase) |
| 3815 | 11 | 16590 | KIT | Mast cell leukemia | 164920 | 9 | 4q11-q12 | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
| 3818 | 5 | 16621 | KLKB1 | Fletcher factor deficiency | 229000 | 3 | 4q34-q35 | kallikrein B, plasma (Fletcher factor) 1 |
| 3827 | 1 | 16644 | KNG | Kininogen deficiency | 228960 | 4 | 3q27 | kininogen |
| 3845 | 2 | 16653 | KRAS2 | Colorectal adenoma | 190070 | 10 | 12p12.1 | v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog |
| 3849 | 16 | 16681 | KRT2A | Ichthyosis bullosa of Siemens | 600194 | 4 | 12q11-q13 | keratin 2A (epidermal ichthyosis bullosa of Siemens) |
| 3851 | 16 | 16682 | KRT4 | White sponge nevus | 123940 | 7 | 12q12-q13 | keratin 4 |
| 3852 | 20 | 106035 | KRT5 | Epidermolysis bullosa simplex with mottled pigmentation | 148040 | 7 | 12q12-q13 | keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
| 3853 | 17 | 16687 | KRT6A | Pachyonychia congenita, Jadassohn-Lewandowsky type | 148041 | 6 | 12q12-q13 | keratin 6A |
| 3858 | 24 | 16661 | KRT10 | Epidermolytic hyperkeratosis | 148080 | 5 | 17q21-q23 | keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) |
| 3859 | 25 | 16662 | KRT12 | Meesmann corneal dystrophy | 601687 | 3 | 17q12 | keratin 12 (Meesmann corneal dystrophy) |
| 3860 | 25 | 16663 | KRT13 | White sponge nevus | 148065 | 5 | 17q21-q23 | keratin 13 |
| 3861 | 26 | 16664 | KRT14 | Epidermolysis bullosa simplex, Koebner, Dowling-Meara, and Weber-Cockayne types, 131900, 131760 | 148066 | 6 | 17q12-q21 | keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner) |
| 3868 | 25 | 16666 | KRT16 | Pachyonychia congenita, Jadassohn-Lewandowsky type | 148067 | 2 | 17q12-q21 | keratin 16 (focal non-epidermolytic palmoplantar keratoderma) |
| 3872 | 26 | 16667 | KRT17 | Pachyonychia congenita, Jackson-Lawler type | 148069 | 5 | 17q12-q21 | keratin 17 |
| 3875 | 22 | 16668 | KRT18 | ?Liver disease, susceptibility to, from hepatotoxins or viruses | 148070 | 14 | 12q13 | keratin 18 |
| 3887 | 16 | 64818 | KRTHB1 | Monilethrix | 602153 | 7 | 12q13 | keratin, hair, basic, 1 |
| 3892 | 16 | 16679 | KRTHB6 | Monilethrix | 601928 | 4 | 12q13 | keratin, hair, basic, 6 (monilethrix) |
| 3897 | 8 | 16728 | L1CAM | Spastic paraplegia | 308840 | 10 | Xq28 | L1 cell adhesion molecule (hydrocephalus, stenosis of aqueduct of Sylvius 1, MASA (mental retardation, aphasia, shuffling gait and adducted thumbs) syndrome, spastic paraplegia 1) |
| 3908 | 8 | 16773 | LAMA2 | Muscular dystrophy, congenital merosin-deficient | 156225 | 4 | 6q22-q23 | laminin, alpha 2 (merosin, congenital muscular dystrophy) |
| 3909 | 2 | 16774 | LAMA3 | Epidermolysis bullosa, generalized atrophic benign | 600805 | 5 | 18q11.2 | laminin, alpha 3 |
| 3914 | 2 | 16780 | LAMB3 | Epidermolysis bullosa, generalized atrophic benign | 150310 | 4 | 1q32 | laminin, beta 3 |
| 3931 | 2 | 16816 | LCAT | Fish-eye disease | 606967 | 7 | 16q22.1 | lecithin-cholesterol acyltransferase |
| 3932 | 35 | 16818 | LCK | SCID due to LCK deficiency | 153390 | 6 | 1p34.3 | lymphocyte-specific protein tyrosine kinase |
| 3939 | 5 | 16828 | LDHA | Exertional myoglobinuria due to deficiency of LDH-A | 150000 | 5 | 11p15.4 | lactate dehydrogenase A |
| 3945 | 5 | 16832 | LDHB | Lactate dehydrogenase-B deficiency | 150100 | 6 | 12p12.2-p12.1 | lactate dehydrogenase B |
| 3949 | 13 | 16835 | LDLR | Hypercholesterolemia, familial | 606945 | 6 | 19p13.3 | low density lipoprotein receptor (familial hypercholesterolemia) |
| 3952 | 1 | 16846 | LEP | Obesity, severe, due to leptin deficiency | 164160 | 8 | 7q31.3 | leptin (obesity homolog, mouse) |
| 3973 | 5 | 16867 | LHCGR | Micropenis | 152790 | 5 | 2p21 | luteinizing hormone/choriogonadotropin receptor |
| 3978 | 1 | 16881 | LIG1 | DNA ligase I deficiency | 126391 | 2 | 19q13.2-q13.3 | ligase I, DNA, ATP-dependent |
| 3988 | 51 | 16889 | LIPA | Wolman disease | 278000 | 7 | 10q23.2-q23.3 | lipase A, lysosomal acid, cholesterol esterase (Wolman disease) |
| 3990 | 6 | 15450 | LIPC | Hepatic lipase deficiency | 151670 | 9 | 15q21-q23 | lipase, hepatic |
| 3998 | 1 | 70361 | LMAN1 | Combined factor V and VIII deficiency | 601567 | 3 | 18q21.3-q22 | lectin, mannose-binding, 1 |
| 4000 | 3 | 16905 | LMNA | Muscular dystrophy, limb-girdle, type 1B | 150330 | 7 | 1q21.2-q21.3 | lamin A/C |
| 4004 | 1 | 109594 | LMO1 | Leukemia, T-cell acute lymphoblastic | 186921 | 2 | 11p15 | LIM domain only 1 (rhombotin 1) |
| 4005 | 1 | 16909 | LMO2 | Leukemia, acute T-cell | 180385 | 2 | 11p13 | LIM domain only 2 (rhombotin-like 1) |
| 4010 | 1 | 16917 | LMX1B | Nail-patella syndrome with open-angle glaucoma | 602575 | 4 | 9q34 | LIM homeobox transcription factor 1, beta |
| 4015 | 5 | 16948 | LOX | Cutis laxa, recessive, type I | 153455 | 5 | 5q23.2 | lysyl oxidase |
| 4023 | 6 | 16956 | LPL | Chylomicronemia syndrome, familial | 238600 | 6 | 8p22 | lipoprotein lipase |
| 4041 | 9 | 16973 | LRP5 | Bone mineral density variability 1 | 603506 | 5 | 11q13.4 | low density lipoprotein receptor-related protein 5 |
| 4053 | 15 | 16997 | LTBP2 | 602091 | 3 | 14q24 | latent transforming growth factor beta binding protein 2 | |
| 4066 | 1 | 17095 | LYL1 | Leukemia, T-cell acute lymphoblastoid | 151440 | 6 | 19p13.2 | lymphoblastic leukemia derived sequence 1 |
| 4068 | 1 | 20400 | SH2D1A | Lymphoproliferative syndrome, X-linked | 308240 | 10 | Xq25-q26 | SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome) |
| 4069 | 2 | 17105 | LYZ | Amyloidosis, renal | 153450 | 7 | 12q13.2 | lysozyme (renal amyloidosis) |
| 4070 | 3 | 56753 | TACSTD2 | Corneal dystrophy, gelatinous drop-like | 137290 | 4 | 1p32-p31 | tumor-associated calcium signal transducer 2 |
| 4089 | 1 | 17128 | MADH4 | Pancreatic cancer | 600993 | 4 | 18q21.1 | MAD, mothers against decapentaplegic homolog 4 (Drosophila) |
| 4125 | 8 | 17159 | MAN2B1 | Mannosidosis, alpha-, types I and II | 248500 | 5 | 19cen-q13.1 | mannosidase, alpha, class 2B, member 1 |
| 4126 | 3 | 110173 | MANBA | Mannosidosis, beta- | 248510 | 2 | 4q22-q25 | mannosidase, beta A, lysosomal |
| 4128 | 4 | 17161 | MAOA | Brunner syndrome | 309850 | 7 | Xp11.4-p11.3 | monoamine oxidase A |
| 4137 | 2 | 17762 | MAPT | Pallidopontonigral degeneration | 157140 | 10 | 17q21.1 | microtubule-associated protein tau |
| 4143 | 3 | 11720 | MAT1A | Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency | 250850 | 4 | 10q22 | methionine adenosyltransferase I, alpha |
| 4153 | 0 | 17194 17195 | MBL2 | Chronic infections, due to opsonin defect | 154545 | 4 | 10q11.2-q21 | mannose-binding lectin (protein C) 2, soluble (opsonic defect) |
| 4157 | 1 | 17199 | MC1R | Red hair/fair skin | 155555 | 2 | 16q24.3 | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
| 4158 | 2 | 17200 | MC2R | Glucocorticoid deficiency, due to ACTH unresponsiveness | 202200 | 2 | 18p11.2 | melanocortin 2 receptor (adrenocorticotropic hormone) |
| 4163 | 1 | 110118 | MCC | Colorectal cancer | 159350 | 3 | 5q21-q22 | mutated in colorectal cancers |
| 4166 | 2 | 56773 | CHST6 | Macular corneal dystrophy | 605294 | 3 | 16q22 | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 |
| 4179 | 1 | 17221 | MCP | Measles, susceptibility to | 120920 | 6 | 1q32 | membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen) |
| 4204 | 2 | 17257 | MECP2 | Angelman syndrome | 300005 | 11 | Xq28 | methyl CpG binding protein 2 (Rett syndrome) |
| 4210 | 5 | 54483 | MEFV | Familial Mediterranean fever | 249100 | 4 | 16p13.3 | Mediterranean fever |
| 4233 | 3 | 17295 | MET | Renal cell carcinoma, papillary, familial and sporadic | 164860 | 9 | 7q31 | met proto-oncogene (hepatocyte growth factor receptor) |
| 4261 | 1 | 12265 | MHC2TA | MHC class II deficiency, complementation group A | 600005 | 3 | 16p13 | MHC class II transactivator |
| 4286 | 3 | 17342 | MITF | Tietz syndrome | 156845 | 7 | 3p14.1-p12.3 | microphthalmia-associated transcription factor |
| 4287 | 2 | 76702 | MJD | Machado-Joseph disease | 607047 | 7 | 14q24.3-q32.2 | Machado-Joseph disease (spinocerebellar ataxia 3, olivopontocerebellar ataxia 3, autosomal dominant, ataxin 3) |
| 4291 | 1 | 17349 | MLF1 | Leukemia, myeloid, acute | 601402 | 3 | 3q25.1 | myeloid leukemia factor 1 |
| 4292 | 2 | 17350 | MLH1 | Cafe-au-lait spots with glioma or leukemia | 120436 | 8 | 3p21.3 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
| 4297 | 2 | 17353 | MLL | Leukemia, myeloid/lymphoid or mixed-lineage | 159555 | 3 | 11q23 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) |
| 4338 | 2 | 17434 | MOCS2 | Molybdenum cofactor deficiency, type B | 603708 | 3 | 5q11 | molybdenum cofactor synthesis 2 |
| 4351 | 2 | 110119 | MPI | Carbohydrate-deficient glycoprotein syndrome, type Ib | 154550 | 2 | 15q22-qter | mannose phosphate isomerase |
| 4353 | 2 | 17523 | MPO | Myeloperoxidase deficiency | 606989 | 12 | 17q23.1 | myeloperoxidase |
| 4359 | 1 | 17528 | MPZ | Dejerine-Sottas disease, myelin P-zero-related | 159440 | 5 | 1q22 | myelin protein zero (Charcot-Marie-Tooth neuropathy 1B) |
| 4436 | 2 | 17685 | MSH2 | Cafe-au-lait spots, multiple, with leukemia | 120435 | 15 | 2p22-p21 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
| 4437 | 6 | 17686 | MSH3 | Endometrial carcinoma | 600887 | 3 | 5q11-q12 | mutS homolog 3 (E. coli) |
| 4487 | 2 | 17701 | MSX1 | Witkop syndrome | 142983 | 4 | 4p16.3-p16.1 | msh homeo box homolog 1 (Drosophila) |
| 4488 | 1 | 17702 | MSX2 | Parietal foramina 1 | 123101 | 7 | 5q34-q35 | msh homeo box homolog 2 (Drosophila) |
| 4524 | 2 | 17769 | MTHFR | Homocystinuria due to MTHFR deficiency | 607093 | 4 | 1p36.3 | 5,10-methylenetetrahydrofolate reductase (NADPH) |
| 4534 | 13 | 17772 | MTM1 | Myotubular myopathy, X-linked | 310400 | 3 | Xq28 | myotubular myopathy 1 |
| 4547 | 1 | 17777 | MTP | Abetalipoproteinemia | 157147 | 4 | 4q24 | microsomal triglyceride transfer protein (large polypeptide, 88kDa) |
| 4548 | 2 | 17774 | MTR | Methylcobalamin deficiency, cbl G type | 156570 | 4 | 1q43 | 5-methyltetrahydrofolate-homocysteine methyltransferase |
| 4591 | 4 | 72353 | TRIM37 | Mulibrey nanism | 605073 | 2 | 17q22-q23 | tripartite motif-containing 37 |
| 4598 | 2 | 17855 | MVK | Hyper-IgD syndrome | 251170 | 4 | 12q24 | mevalonate kinase (mevalonic aciduria) |
| 4607 | 4 | 17868 | MYBPC3 | Cardiomyopathy, familial hypertrophic, 4 | 600958 | 6 | 11p11.2 | myosin binding protein C, cardiac |
| 4609 | 1 | 17869 | MYC | Burkitt lymphoma | 190080 | 9 | 8q24.12-q24.13 | v-myc myelocytomatosis viral oncogene homolog (avian) |
| 4625 | 26 | 140781 | MYH7 | Cardiomyopathy, familial hypertrophic, 1 | 160760 | 13 | 14q12 | myosin, heavy polypeptide 7, cardiac muscle, beta |
| 4633 | 3 | 17906 | MYL2 | Cardiomyopathy, hypertrophic, mid-left ventricular chamber type | 160781 | 7 | 12q23-q24.3 | myosin, light polypeptide 2, regulatory, cardiac, slow |
| 4634 | 5 | 17897 | MYL3 | Cardiomopathy, hypertrophic, mid-ventricular chamber type | 160790 | 8 | 3p21.3-p21.2 | myosin, light polypeptide 3, alkali; ventricular, skeletal, slow |
| 4644 | 26 | 17918 | MYO5A | Griscelli syndrome-type pigmentary dilution with mental retardation | 160777 | 4 | 15q21 | myosin VA (heavy polypeptide 12, myoxin) |
| 4647 | 23 | 17921 | MYO7A | Deafness, autosomal recessive 2, neurosensory | 276903 | 2 | 11q13.5 | myosin VIIA (Usher syndrome 1B (autosomal recessive, severe)) |
| 4653 | 1 | 17926 | MYOC | Glaucoma 1A, primary open angle, juvenile-onset | 601652 | 7 | 1q23-q24 | myocilin, trabecular meshwork inducible glucocorticoid response |
| 4668 | 3 | 17939 | NAGA | Schindler disease | 104170 | 6 | 22q11 | N-acetylgalactosaminidase, alpha- |
| 4669 | 1 | 27419 | NAGLU | Sanfilippo syndrome, type B | 252920 | 6 | 17q21 | N-acetylglucosaminidase, alpha- (Sanfilippo disease IIIB) |
| 4683 | 1 | 27354 | NBS1 | Leukemia, acute lymphoblastic | 602667 | 6 | 8q21-q24 | Nijmegen breakage syndrome 1 (nibrin) |
| 4687 | 1 | 17969 | NCF1 | Chronic granulomatous disease due to deficiency of NCF-1 | 233700 | 6 | 7q11.23 | neutrophil cytosolic factor 1 (47kDa, chronic granulomatous disease, autosomal 1) |
| 4688 | 1 | 17970 | NCF2 | Chronic granulomatous disease due to deficiency of NCF-2 | 233710 | 3 | 1q25 | neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2) |
| 4703 | 2 | 17996 | NEB | Nemaline myopathy 2, autosomal recessive | 161650 | 7 | 2q22 | nebulin |
| 4723 | 2 | 17995 | NDUFV1 | Alexander disease | 161015 | 4 | 11q13 | NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa |
| 4724 | 2 | 17993 | NDUFS4 | Complex I deficiency | 602694 | 3 | 5q11.1 | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) |
| 4758 | 1 | 18010 | NEU1 | Sialidosis, type II | 256550 | 4 | 6p21.3 | sialidase 1 (lysosomal sialidase) |
| 4763 | 3 | 18015 | NF1 | Watson syndrome | 162200 | 19 | 17q11.2 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) |
| 4771 | 8 | 18016 | NF2 | Schwannoma, sporadic | 101000 | 6 | 22q12.2 | neurofibromin 2 (bilateral acoustic neuroma) |
| 4830 | 4 | 18102 | NME1 | Neuroblastoma | 156490 | 7 | 17q21.3 | non-metastatic cells 1, protein (NM23A) expressed in |
| 4846 | 1 | 18127 | NOS3 | Coronary spasm, susceptibility to | 163729 | 3 | 7q36 | nitric oxide synthase 3 (endothelial cell) |
| 4851 | 12 | 18128 | NOTCH1 | Leukemia, T-cell acute lymphoblastic | 190198 | 2 | 9q34.3 | Notch homolog 1, translocation-associated (Drosophila) |
| 4854 | 11 | 18131 | NOTCH3 | Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy | 600276 | 5 | 19p13.2-p13.1 | Notch homolog 3 (Drosophila) |
| 4860 | 2 | 18950 | NP | Nucleoside phosphorylase deficiency, immunodeficiency due to | 164050 | 4 | 14q13.1 | nucleoside phosphorylase |
| 4864 | 1 | 18145 | NPC1 | Niemann-Pick disease, type C1 | 257220 | 2 | 18q11-q12 | Niemann-Pick disease, type C1 |
| 4869 | 5 | 18148 | NPM1 | Leukemia, acute promyelocytic, NPM/RARA type | 164040 | 17 | 5q35 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
| 4893 | 2 | 18176 | NRAS | Colorectal cancer | 164790 | 9 | 1p13.2 | neuroblastoma RAS viral (v-ras) oncogene homolog |
| 4901 | 3 | 18185 | NRL | Retinitis pigmentosa, autosomal dominant | 162080 | 4 | 14q11.1-q11.2 | neural retina leucine zipper |
| 4902 | 1 | 18188 | NRTN | Hirschsprung disease | 602018 | 3 | 19p13.3 | neurturin |
| 4914 | 31 | 18211 | NTRK1 | Insensitivity to pain, congenital, with anhidrosis | 191315 | 7 | 1q21-q22 | neurotrophic tyrosine kinase, receptor, type 1 |
| 4920 | 14 | 26564 | ROR2 | Robinow syndrome, autosomal recessive | 602337 | 2 | 9q22 | receptor tyrosine kinase-like orphan receptor 2 |
| 4935 | 1 | 18241 | OA1 | Ocular albinism, Nettleship-Falls type | 300500 | 3 | Xp22.3 | ocular albinism 1 (Nettleship-Falls) |
| 4948 | 2 | 18431 | OCA2 | Albinism, ocular, autosomal recessive | 203200 | 5 | 15q11.2-q12 | oculocutaneous albinism II (pink-eye dilution homolog, mouse) |
| 4952 | 8 | 107544 | OCRL | Lowe syndrome | 309000 | 7 | Xq25-q26.1 | oculocerebrorenal syndrome of Lowe |
| 4967 | 3 | 18293 | OGDH | Alpha-ketoglutarate dehydrogenase deficiency | 203740 | 4 | 7p14-p13 | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
| 4976 | 7 | 12219 | OPA1 | Glaucoma, normal tension, susceptibility to | 605290 | 10 | 3q28-q29 | optic atrophy 1 (autosomal dominant) |
| 4983 | 11 | 94190 | OPHN1 | Mental retardation, X-linked, 60 | 300127 | 4 | Xq12 | oligophrenin 1 |
| 5002 | 1 | 18400 | SLC22A1L | Rhabdomyosarcoma | 602631 | 6 | 11p15.5 | solute carrier family 22 (organic cation transporter), member 1-like |
| 5009 | 1 | 18416 | OTC | Ornithine transcarbamylase deficiency | 311250 | 7 | Xp21.1 | ornithine carbamoyltransferase |
| 5019 | 5 | 64059 | OXCT | Ketoacidosis due to SCOT deficiency | 245050 | 4 | 5p13 | 3-oxoacid CoA transferase |
| 5054 | 5 | 18787 | SERPINE1 | Thrombophilia due to excessive plasminogen activator inhibitor | 173360 | 8 | 7q21.3-q22 | serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
| 5063 | 11 | 18481 | PAK3 | Mental retardation, X-linked 30 | 300142 | 2 | Xq22.3-q23 | p21 (CDKN1A)-activated kinase 3 |
| 5076 | 5 | 18504 | PAX2 | Optic nerve coloboma with renal disease | 167409 | 10 | 10q22.1-q24.3 | paired box gene 2 |
| 5077 | 9 | 18505 | PAX3 | Craniofacial-deafness-hand syndrome | 193500 | 12 | 2q35 | paired box gene 3 (Waardenburg syndrome 1) |
| 5080 | 5 | 18508 | PAX6 | Eye anomalies, multiplex | 607108 | 9 | 11p13 | paired box gene 6 (aniridia, keratitis) |
| 5081 | 6 | 18509 | PAX7 | Rhabdomyosarcoma, alveolar | 167410 | 7 | 1p36.2-p36.12 | paired box gene 7 |
| 5087 | 2 | 18514 | PBX1 | Leukemia, acute pre-B-cell | 176310 | 2 | 1q23 | pre-B-cell leukemia transcription factor 1 |
| 5091 | 5 | 18563 | PC | Pyruvate carboxylase deficiency | 266150 | 8 | 11q13.4-q13.5 | pyruvate carboxylase |
| 5092 | 1 | 13180 | PCBD | Hyperphenylalaninemia due to pterin-4a-carbinolamine dehydratase deficiency | 126090 | 8 | 10q22 | 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) |
| 5095 | 4 | 110821 | PCCA | Propionicacidemia | 232000 | 6 | 13q32 | propionyl Coenzyme A carboxylase, alpha polypeptide |
| 5096 | 2 | 66904 | PCCB | Propionicacidemia | 232050 | 3 | 3q21-q22 | propionyl Coenzyme A carboxylase, beta polypeptide |
| 5104 | 10 | 18533 | SERPINA5 | Protein C inhibitor deficiency | 601841 | 4 | 14q32.1 | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
| 5122 | 2 | 18548 | PCSK1 | Obestiy with impaired prohormone processing | 162150 | 5 | 5q15-q21 | proprotein convertase subtilisin/kexin type 1 |
| 5145 | 4 | 18586 | PDE6A | Retinitis pigmentosa, autosomal recessive | 180071 | 3 | 5q31.2-q34 | phosphodiesterase 6A, cGMP-specific, rod, alpha |
| 5158 | 3 | 18587 | PDE6B | Night blindness, congenital stationary, type 3 | 180072 | 5 | 4p16.3 | phosphodiesterase 6B, cGMP-specific, rod, beta (congenital stationary night blindness 3, autosomal dominant) |
| 5160 | 2 | 18597 | PDHA1 | Pyruvate dehydrogenase deficiency | 312170 | 10 | Xp22.2-p22.1 | pyruvate dehydrogenase (lipoamide) alpha 1 |
| 5172 | 9 | 23985 | SLC26A4 | Pendred syndrome | 605646 | 3 | 7q31 | solute carrier family 26, member 4 |
| 5184 | 1 | 18624 | PEPD | Prolidase deficiency | 170100 | 5 | 19q12-q13.2 | peptidase D |
| 5189 | 8 | 71382 | PEX1 | Adrenoleukodystrophy, neonatal | 602136 | 6 | 7q21-q22 | peroxisome biogenesis factor 1 |
| 5191 | 2 | 18634 | PEX7 | Rhizomelic chondrodysplasia punctata, type 1 | 601757 | 4 | 6q21-q22.2 | peroxisomal biogenesis factor 7 |
| 5211 | 12 | 18641 | PFKL | Hemolytic anemia due to phosphofructokinase deficiency | 171860 | 6 | 21q22.3 | phosphofructokinase, liver |
| 5213 | 13 | 18642 | PFKM | Glycogen storage disease VII | 232800 | 7 | 12q13.3 | phosphofructokinase, muscle |
| 5224 | 6 | 56012 | PGAM2 | Myopathy due to phosphoglycerate mutase deficiency | 261670 | 4 | 7p13-p12 | phosphoglycerate mutase 2 (muscle) |
| 5230 | 1 | 18655 | PGK1 | Myoglobinuria/hemolysis due to PGK deficiency | 311800 | 5 | Xq13 | phosphoglycerate kinase 1 |
| 5243 | 15 | 18669 | ABCB1 | Colchicine resistance | 171050 | 9 | 7q21.1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
| 5244 | 14 | 18671 | ABCB4 | Cholestasis, progressive familial intrahepatic, type III | 171060 | 6 | 7q21.1 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
| 5245 | 4 | 18673 | PHB | Breast cancer, sporadic | 176705 | 4 | 17q21 | prohibitin |
| 5251 | 6 | 18675 | PHEX | Hypophosphatemia, hereditary | 307800 | 5 | Xp22.2-p22.1 | phosphate regulating gene with homologies to endopeptidases on the X chromosome (hypophosphatemia, vitamin D resistant rickets) |
| 5255 | 6 | 18679 | PHKA1 | Muscle glycogenosis | 311870 | 2 | Xq12-q13 | phosphorylase kinase, alpha 1 (muscle) |
| 5256 | 5 | 110094 | PHKA2 | Glycogenosis, X-linked hepatic, type II | 306000 | 3 | Xp22.2-p22.1 | phosphorylase kinase, alpha 2 (liver) |
| 5261 | 2 | 68961 | PHKG2 | Glycogenosis, hepatic, autosomal | 172471 | 4 | 16p12.1-p11.2 | phosphorylase kinase, gamma 2 (testis) |
| 5265 | 17 | 20699 | SERPINA1 | Emphysema-cirrhosis | 107400 | 6 | 14q32.1 | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| 5277 | 3 | 18700 | PIGA | Paroxysmal nocturnal hemoglobinuria | 311770 | 6 | Xp22.1 | phosphatidylinositol glycan, class A (paroxysmal nocturnal hemoglobinuria) |
| 5290 | 8 | 18706 | PIK3CA | Ovarian cancer | 171834 | 2 | 3q26.3 | phosphoinositide-3-kinase, catalytic, alpha polypeptide |
| 5310 | 1 | 18763 | PKD1 | Polycystic kidney disease, adult type I | 601313 | 4 | 16p13.3 | polycystic kidney disease 1 (autosomal dominant) |
| 5311 | 3 | 18764 | PKD2 | Polycystic kidney disease, adult, type II | 173910 | 4 | 4q21-q23 | polycystic kidney disease 2 (autosomal dominant) |
| 5313 | 1 | 18770 | PKLR | Anemia, hemolytic, due to PK deficiency | 266200 | 4 | 1q21 | pyruvate kinase, liver and RBC |
| 5317 | 8 | 18772 | PKP1 | Ectodermal dysplasia/skin fragility syndrome | 601975 | 4 | 1q32 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) |
| 5327 | 2 | 18791 | PLAT | Plasminogen activator deficiency | 173370 | 17 | 8p12 | plasminogen activator, tissue |
| 5339 | 4 | 18810 | PLEC1 | Muscular dystrophy with epidermolysis bullosa simplex | 601282 | 3 | 8q24 | plectin 1, intermediate filament binding protein 500kDa |
| 5340 | 3 | 18815 | PLG | Plasminogen deficiency, types I and II | 173350 | 2 | 6q26 | plasminogen |
| 5345 | 2 | 18816 | SERPINF2 | Plasmin inhibitor deficiency | 262850 | 3 | 17p13 | serine (or cysteine) proteinase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
| 5351 | 6 | 18822 | PLOD | Ehlers-Danlos syndrome, type VI | 153454 | 3 | 1p36.3-p36.2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase, Ehlers-Danlos syndrome type VI) |
| 5354 | 5 | 18823 | PLP1 | Pelizaeus-Merzbacher disease | 300401 | 6 | Xq22 | proteolipid protein 1 (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated) |
| 5371 | 4 | 18854 | PML | Leukemia, acute promyelocytic, PML/RARA type | 102578 | 32 | 15q22 | promyelocytic leukemia |
| 5373 | 6 | 54128 | PMM2 | Carbohydrate-deficient glycoprotein syndrome, type I | 601785 | 3 | 16p13.3-p13.2 | phosphomannomutase 2 |
| 5376 | 1 | 18858 | PMP22 | Neuropathy, recurrent, with pressure palsies | 601097 | 6 | 17p12-p11.2 | peripheral myelin protein 22 |
| 5395 | 4 | 18861 | PMS2 | Colorectal cancer, hereditary nonpolyposis, type 4 | 600259 | 3 | 7p22 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) |
| 5406 | 3 | 109716 | PNLIP | Pancreatic lipase deficiency | 246600 | 5 | 10q26.1 | pancreatic lipase |
| 5443 | 4 | 18976 | POMC | ACTH deficiency | 176830 | 5 | 2p23.3 | proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin) |
| 5445 | 3 | 18980 | PON2 | Coronary artery disease, susceptibility to | 602447 | 3 | 7q21.3 | paraoxonase 2 |
| 5456 | 1 | 18994 | POU3F4 | Deafness, X-linked 3, conductive, with stapes fixation | 300039 | 3 | Xq21.1 | POU domain, class 3, transcription factor 4 |
| 5459 | 3 | 18998 | POU4F3 | Deafness, autosomal dominant 15 | 602460 | 2 | 5q31 | POU domain, class 4, transcription factor 3 |
| 5468 | 3 | 19016 | PPARG | Insulin resistance, severe, digenic | 601487 | 12 | 3p25 | peroxisome proliferative activated receptor, gamma |
| 5476 | 2 | 19025 | PPGB | Galactosialidosis | 256540 | 3 | 20q13.1 | protective protein for beta-galactosidase (galactosialidosis) |
| 5498 | 1 | 19044 | PPOX | Porphyria variegata | 600923 | 4 | 1q22 | protoporphyrinogen oxidase |
| 5538 | 1 | 19063 | PPT1 | Ceroid lipofuscinosis, neuronal, variant juvenile type, with granular osmiophilic deposits | 600722 | 5 | 1p32 | palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) |
| 5546 | 1 | 94315 | PRCC | Renal cell carcinoma, papillary, 1 | 179755 | 5 | 1q21.1 | papillary renal cell carcinoma (translocation-associated) |
| 5578 | 34 | 18750 | PRKCA | Pituitary tumor, invasive | 176960 | 2 | 17q22-q23.2 | protein kinase C, alpha |
| 5624 | 1 | 19123 | PROC | Thrombophilia due to protein C deficiency | 176860 | 4 | 2q13-q14 | protein C (inactivator of coagulation factors Va and VIIIa) |
| 5627 | 1 | 19128 | PROS1 | Protein S deficiency | 176880 | 7 | 3p11-q11.2 | protein S (alpha) |
| 5631 | 15 | 19139 | PRPS1 | Phosphoribosyl pyrophosphate synthetase-related gout | 311850 | 4 | Xq21-q27 | phosphoribosyl pyrophosphate synthetase 1 |
| 5651 | 7 | 19146 | PRSS7 | Enterokinase deficiency | 606635 | 2 | 21q21.1 | protease, serine, 7 (enterokinase) |
| 5660 | 5 | 19156 | PSAP | Combined SAP deficiency | 176801 | 9 | 10q21-q22 | prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) |
| 5663 | 1 | 19164 | PSEN1 | Alzheimer disease-3, early onset | 104311 | 10 | 14q24.3 | presenilin 1 (Alzheimer disease 3) |
| 5664 | 1 | 19165 | PSEN2 | Alzheimer disease-4 | 600759 | 7 | 1q31-q42 | presenilin 2 (Alzheimer disease 4) |
| 5728 | 3 | 19211 | PTEN | Prostate cancer, susceptibility to | 601728 | 6 | 10q23.3 | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) |
| 5745 | 9 | 19228 | PTHR1 | Enchondromatosis, Ollier type | 168468 | 5 | 3p22-p21.1 | parathyroid hormone receptor 1 |
| 5781 | 1 | 19247 | PTPN11 | ?Cardiofaciocutaneous syndrome | 176876 | 8 | 12q24.1 | protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1) |
| 5805 | 1 | 19286 | PTS | Phenylketonuria due to PTS deficiency | 261640 | 8 | 11q22.3-q23.3 | 6-pyruvoyltetrahydropterin synthase |
| 5817 | 4 | 19294 19295 | PVR | Polio, susceptibility to | 173850 | 7 | 19q13.2 | poliovirus receptor |
| 5818 | 1 | 58235 | PVRL1 | Cleft lip/palate ectodermal dysplasia syndrome | 600644 | 4 | 11q23 | poliovirus receptor-related 1 (herpesvirus entry mediator C; nectin) |
| 5825 | 5 | 19299 | ABCD3 | Zellweger syndrome-2 | 170995 | 4 | 1p22-p21 | ATP-binding cassette, sub-family D (ALD), member 3 |
| 5830 | 4 | 19305 | PXR1 | Zellweger syndrome | 600414 | 3 | 12p13.3 | peroxisome receptor 1 |
| 5836 | 1 | 110095 | PYGL | Glycogen storage disease VI | 232700 | 5 | 14q21-q22 | phosphorylase, glycogen; liver (Hers disease, glycogen storage disease type VI) |
| 5837 | 2 | 19309 | PYGM | McArdle disease | 232600 | 3 | 11q12-q13.2 | phosphorylase, glycogen; muscle (McArdle syndrome, glycogen storage disease type V) |
| 5860 | 2 | 110391 | QDPR | Phenylketonuria due to dihydropteridine reductase deficiency | 261630 | 5 | 4p15.31 | quinoid dihydropteridine reductase |
| 5896 | 2 | 19373 | RAG1 | Omenn syndrome | 179615 | 2 | 11p13 | recombination activating gene 1 |
| 5897 | 3 | 19374 | RAG2 | Omenn syndrome | 179616 | 1 | 11p13 | recombination activating gene 2 |
| 5914 | 3 | 19401 | RARA | Leukemia, acute promyelocytic | 180240 | 6 | 17q12 | retinoic acid receptor, alpha |
| 5925 | 1 | 19645 | RB1 | Retinoblastoma | 180200 | 6 | 13q14.2 | retinoblastoma 1 (including osteosarcoma) |
| 5956 | 2 | 20164 | OPN1LW | Colorblindness, protan | 303900 | 3 | Xq28 | opsin 1 (cone pigments), long-wave-sensitive (color blindness, protan) |
| 5961 | 1 | 19133 | RDS | Foveomacular dystrophy, adult-onset, with choroidal neovascularization | 179605 | 3 | 6p21.2-12.3 | retinal degeneration, slow (retinitis pigmentosa 7) |
| 5972 | 8 | 19701 | REN | Hyperproreninemia | 179820 | 9 | 1q32 | renin |
| 5979 | 28 | 19713 | RET | Multiple endocrine neoplasia IIB | 164761 | 19 | 10q11.2 | ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) |
| 5993 | 2 | 53970 | RFX5 | MHC class II deficiency, complementation group C | 601863 | 4 | 1q21 | regulatory factor X, 5 (influences HLA class II expression) |
| 6005 | 4 | 19743 | RHAG | Rh-mod syndrome | 180297 | 3 | 6p21.1-p11 | Rhesus blood group-associated glycoprotein |
| 6010 | 2 | 19747 | RHO | Night blindness, congenital stationery, rhodopsin-related | 180380 | 4 | 3q21-q24 | rhodopsin (opsin 2, rod pigment) (retinitis pigmentosa 4, autosomal dominant) |
| 6011 | 2 | 24013 | RHOK | Oguchi disease-2 | 180381 | 2 | 13q34 | rhodopsin kinase |
| 6017 | 1 | 19771 | RLBP1 | Newfoundland rod-cone dystrophy | 180090 | 4 | 15q26 | retinaldehyde binding protein 1 |
| 6101 | 1 | 19888 | RP1 | Retinitis pigmentosa-1 | 603937 | 6 | 8q11-q13 | retinitis pigmentosa 1 (autosomal dominant) |
| 6102 | 5 | 19889 | RP2 | Retinitis pigmentosa-2 | 312600 | 2 | Xp11.4-p11.21 | retinitis pigmentosa 2 (X-linked recessive) |
| 6103 | 5 | 19893 | RPGR | Retinitis pigmentosa, X-linked, with recurrent respiratory infections | 312610 | 3 | Xp21.1 | retinitis pigmentosa GTPase regulator |
| 6121 | 2 | 19892 | RPE65 | Retinal dystrophy, autosomal recessive, childhood-onset | 180069 | 4 | 1p31 | retinal pigment epithelium-specific protein 65kDa |
| 6191 | 9 | 20102 | RPS4X | 312760 | 9 | Xq13.1 | ribosomal protein S4, X-linked | |
| 6197 | 36 | 110651 | RPS6KA3 | Mental retardation, X-linked nonspecific, type 19 | 300075 | 3 | Xp22.2-p22.1 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| 6223 | 4 | 20085 | RPS19 | Anemia, Diamond-Blackfan | 603474 | 8 | 19q13.2 | ribosomal protein S19 |
| 6261 | 2 | 20190 | RYR1 | Malignant hyperthermia susceptibility 1 | 180901 | 3 | 19q13.1 | ryanodine receptor 1 (skeletal) |
| 6295 | 5 | 20215 | SAG | Oguchi disease-1 | 181031 | 4 | 2q37.1 | S-antigen; retina and pineal gland (arrestin) |
| 6296 | 10 | 20216 | SAH | ?Hypertension, essential | 145505 | 5 | 16p13.11 | SA hypertension-associated homolog (rat) |
| 6299 | 2 | 58198 | SALL1 | Townes-Brocks syndrome | 602218 | 4 | 16q12.1 | sal-like 1 (Drosophila) |
| 6310 | 1 | 20238 | SCA1 | Spinocerebellar ataxia-1 | 601556 | 3 | 6p23 | spinocerebellar ataxia 1 (olivopontocerebellar ataxia 1, autosomal dominant, ataxin 1) |
| 6311 | 1 | 20239 | SCA2 | Spinocerebellar ataxia-2 | 601517 | 3 | 12q24 | spinocerebellar ataxia 2 (olivopontocerebellar ataxia 2, autosomal dominant, ataxin 2) |
| 6329 | 3 | 110880 | SCN4A | Myotonia congenita, atypical, acetazolamide-responsive | 603967 | 5 | 17q23-q25.3 | sodium channel, voltage-gated, type IV, alpha polypeptide |
| 6331 | 3 | 20271 | SCN5A | Heart block, progressive, type I | 600163 | 2 | 3p21 | sodium channel, voltage-gated, type V, alpha polypeptide (long (electrocardiographic) QT syndrome 3) |
| 6337 | 3 | 20276 | SCNN1A | Pseudohypoaldosteronism, type I | 600228 | 5 | 12p13 | sodium channel, nonvoltage-gated 1 alpha |
| 6338 | 3 | 20277 | SCNN1B | Liddle syndrome | 600760 | 3 | 16p12.2-p12.1 | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
| 6340 | 3 | 20278 | SCNN1G | Liddle syndrome | 600761 | 2 | 16p12 | sodium channel, nonvoltage-gated 1, gamma |
| 6389 | 8 | 66945 | SDHA | Leigh syndrome | 600857 | 6 | 5p15 | succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
| 6399 | 8 | 66050 | SEDL | Spondyloepiphyseal dysplasia tarda | 300202 | 4 | Xp22 | spondyloepiphyseal dysplasia, late |
| 6403 | 1 | 20344 | SELP | Platelet alpha/delta storage pool deficiency | 173610 | 4 | 1q22-q25 | selectin P (granule membrane protein 140kDa, antigen CD62) |
| 6442 | 3 | 20391 | SGCA | Muscular dystrophy, limb-girdle, type 2D | 600119 | 5 | 17q21 | sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) |
| 6443 | 2 | 24051 | SGCB | Muscular dystrophy, limb-girdle, type 2E | 600900 | 6 | 4q12 | sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
| 6444 | 3 | 24052 | SGCD | Cardiomyopathy, dilated, 1L | 601411 | 4 | 5q33-q34 | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
| 6445 | 2 | 24053 | SGCG | Muscular dystrophy, limb-girdle, type 2C | 253700 | 2 | 13q12 | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) |
| 6448 | 3 | 27029 | SGSH | Sanfilippo syndrome, type A | 252900 | 3 | 17q25.3 | N-sulfoglucosamine sulfohydrolase (sulfamidase) |
| 6469 | 5 | 20423 | SHH | Holoprosencephaly-3 | 600725 | 4 | 7q36 | sonic hedgehog homolog (Drosophila) |
| 6476 | 8 | 20433 | SI | Sucrose intolerance | 222900 | 2 | 3q25.2-q26.2 | sucrase-isomaltase |
| 6513 | 5 | 20525 | SLC2A1 | Glucose transport defect, blood-brain barrier | 138140 | 3 | 1p35-p31.3 | solute carrier family 2 (facilitated glucose transporter), member 1 |
| 6514 | 5 | 20526 | SLC2A2 | Diabetes mellitus, noninsulin-dependent | 138160 | 2 | 3q26.1-q26.2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
| 6517 | 5 | 20528 | SLC2A4 | Diabetes mellitus, noninsulin-dependent | 138190 | 3 | 17p13 | solute carrier family 2 (facilitated glucose transporter), member 4 |
| 6519 | 2 | 20532 | SLC3A1 | Cystinuria | 104614 | 6 | 2p16.3 | solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1 |
| 6521 | 11 | 20533 | SLC4A1 | Elliptocytosis, Malaysian-Melanesian type | 109270 | 3 | 17q21-q22 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) |
| 6523 | 10 | 20537 | SLC5A1 | Glucose/galactose malabsorption | 182380 | 4 | 22q12.3 | solute carrier family 5 (sodium/glucose cotransporter), member 1 |
| 6525 | 5 | 29856 | SMTN | 602127 | 12 | 22q12.2 | smoothelin | |
| 6528 | 4 | 114479 | SLC5A5 | Hypothyroidism, congenital | 601843 | 3 | 19p13.2-p12 | solute carrier family 5 (sodium iodide symporter), member 5 |
| 6531 | 21 | 13162 | SLC6A3 | Attention-deficit hyperactivity disorder, susceptibility to | 126455 | 5 | 5p15.3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
| 6532 | 24 | 15567 | SLC6A4 | Anxiety-related personality traits | 182138 | 3 | 17q11.1-q12 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
| 6555 | 1 | 20494 | SLC10A2 | Bile acid malabsorption, primary | 601295 | 3 | 13q33 | solute carrier family 10 (sodium/bile acid cotransporter family), member 2 |
| 6557 | 5 | 20495 | SLC12A1 | Bartter syndrome, antenatal | 600839 | 2 | 15q15-q21.1 | solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
| 6559 | 3 | 20497 | SLC12A3 | Gitelman syndrome | 600968 | 3 | 16q13 | solute carrier family 12 (sodium/chloride transporters), member 3 |
| 6584 | 6 | 20520 | SLC22A5 | Carnitine deficiency, systemic primary | 603377 | 4 | 5q31 | solute carrier family 22 (organic cation transporter), member 5 |
| 6598 | 2 | 20587 | SMARCB1 | Rhabdoid tumors | 601607 | 4 | 22q11.23 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 |
| 6608 | 1 | 20596 | SMOH | Basal cell carcinoma, sporadic | 601500 | 4 | 7q32.3 | smoothened homolog (Drosophila) |
| 6609 | 1 | 20597 | SMPD1 | Niemann-Pick disease, type B | 257200 | 8 | 11p15.4-p15.1 | sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase) |
| 6647 | 2 | 20655 | SOD1 | Amytrophic lateral sclerosis, due to SOD1 deficiency | 147450 | 6 | 21q22.11 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) |
| 6662 | 10 | 20682 | SOX9 | Acampomelic campolelic dysplasia | 114290 | 4 | 17q24.3-q25.1 | SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) |
| 6663 | 10 | 20665 | SOX10 | Yemenite deaf-blind hypopigmentation syndrome | 602229 | 4 | 22q13.1 | SRY (sex determining region Y)-box 10 |
| 6683 | 11 | 50850 | SPG4 | Spastic paraplegia-4 | 604277 | 4 | 2p24-p21 | spastic paraplegia 4 (autosomal dominant; spastin) |
| 6708 | 3 | 20739 | SPTA1 | Pyropoikilocytosis | 182860 | 3 | 1q21 | spectrin, alpha, erythrocytic 1 (elliptocytosis 2) |
| 6710 | 8 | 20741 | SPTB | Elliptocytosis-3 | 182870 | 3 | 14q23-q24.2 | spectrin, beta, erythrocytic (includes spherocytosis, clinical type I) |
| 6736 | 83 | 21674 | SRY | Gonadal dysgenesis, XY type | 480000 | 8 | Yp11.3 | sex determining region Y |
| 6752 | 9 | 20606 | SSTR2 | Lung cancer, small cell | 182452 | 4 | 17q24 | somatostatin receptor 2 |
| 6760 | 3 | 20836 | SS18 | Sarcoma, synovial | 600192 | 2 | 18q11.2 | synovial sarcoma translocation, chromosome 18 |
| 6770 | 3 | 20845 | STAR | Lipoid adrenal hyperplasia | 600617 | 5 | 8p11.2 | steroidogenic acute regulatory protein |
| 6794 | 1 | 20869 | STK11 | Peutz-Jeghers syndrome | 602216 | 6 | 19p13.3 | serine/threonine kinase 11 (Peutz-Jeghers syndrome) |
| 6833 | 10 | 20927 | ABCC8 | Persistent hyperinsulinemic hypoglycemia of infancy | 600509 | 8 | 11p15.1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
| 6834 | 1 | 111342 | SURF1 | Leigh syndrome, due to COX deficiency | 185620 | 3 | 9q34.2 | surfeit 1 |
| 6891 | 12 | 21355 | TAP2 | Bare lymphocyte syndrome, type I, due to TAP2 deficiency | 170261 | 18 | 6p21.3 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
| 6898 | 1 | 21365 | TAT | Tyrosinemia, type II | 276600 | 4 | 16q22.1 | tyrosine aminotransferase |
| 6901 | 4 | 21368 | TAZ | Noncompaction of left ventricular myocardium, isolated | 300394 | 3 | Xq28 | tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
| 6910 | 8 | 21388 | TBX5 | Holt-Oram syndrome | 601620 | 8 | 12q24.1 | T-box 5 |
| 6916 | 3 | 21391 | TBXAS1 | Thromboxane synthase deficiency | 274180 | 8 | 7q34-q35 | thromboxane A synthase 1 (platelet, cytochrome P450, subfamily V) |
| 6926 | 7 | 21386 | TBX3 | Ulnar-mammary syndrome | 601621 | 7 | 12q24.1 | T-box 3 (ulnar mammary syndrome) |
| 6927 | 2 | 21405 | TCF1 | MODY, type III | 600496 | 4 | 12q24.2 | transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor |
| 6928 | 2 | 21410 | TCF2 | MODY, type V | 189907 | 6 | 17cen-q21.3 | transcription factor 2, hepatic; LF-B3; variant hepatic nuclear factor |
| 6929 | 7 | 21423 | TCF3 | Leukemia, acute lymphoblastic | 147141 | 4 | 19p13.3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) |
| 6949 | 1 | 21453 | TCOF1 | Treacher Collins mandibulofacial dysostosis | 606847 | 5 | 5q32-q33.1 | Treacher Collins-Franceschetti syndrome 1 |
| 6955 | 4 | 21473 | TRA@ | Leukemia/lymphoma, T-cell | 186880 | 4 | 14q11.2 | T cell receptor alpha locus |
| 7007 | 10 | 21683 | TECTA | Deafness, autosomal recessive 21 | 602574 | 2 | 11q22-q24 | tectorin alpha |
| 7010 | 17 | 21687 | TEK | Venous malformations, multiple cutaneous and mucosal | 600221 | 2 | 9p21 | TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) |
| 7018 | 5 | 22041 | TF | Atransferrinemia | 190000 | 13 | 3q21 | transferrin |
| 7038 | 6 | 21819 | TG | Hypothyroidism, hereditary congenital | 188450 | 5 | 8q24.2-q24.3 | thyroglobulin |
| 7044 | 1 | 13590 | EBAF | Left-right axis malformation | 601877 | 3 | 1q42.1 | endometrial bleeding associated factor (left-right determination, factor A; transforming growth factor beta superfamily) |
| 7045 | 2 | 21810 | TGFBI | Corneal dystrophy, lattice type IIIA | 601692 | 5 | 5q31 | transforming growth factor, beta-induced, 68kDa |
| 7048 | 8 | 21813 | TGFBR2 | Esophageal cancer | 190182 | 5 | 3p22 | transforming growth factor, beta receptor II (70/80kDa) |
| 7050 | 2 | 21815 | TGIF | Holoprosencephaly-4 | 602630 | 3 | 18p11.3 | TGFB-induced factor (TALE family homeobox) |
| 7051 | 11 | 21816 | TGM1 | Ichthyosis, lamellar, autosomal recessive | 190195 | 6 | 14q11.2 | transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
| 7056 | 2 | 21824 | THBD | Thrombophilia due to thrombomodulin defect | 188040 | 5 | 20p12-cen | thrombomodulin |
| 7066 | 1 | 21832 | THPO | Thrombocythemia, essential | 600044 | 9 | 3q27 | thrombopoietin (myeloproliferative leukemia virus oncogene ligand, megakaryocyte growth and development factor) |
| 7068 | 1 | 21834 | THRB | Thyroid hormone resistance, 274300 | 190160 | 3 | 3p24.3 | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) |
| 7078 | 3 | 21859 | TIMP3 | Sorsby fundus dystrophy | 188826 | 13 | 22q12.3 | tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) |
| 7086 | 6 | 21881 | TKT | Wernicke-Korsakoff syndrome, susceptibility to | 606781 | 5 | 3p14.3 | transketolase (Wernicke-Korsakoff syndrome) |
| 7137 | 1 | 21954 | TNNI3 | Cardiomyopathy, familial hypertrophic | 191044 | 4 | 19q13.4 | troponin I, cardiac |
| 7157 | 4 | 22059 | TP53 | Multiple malignancy syndrome | 191170 | 24 | 17p13.1 | tumor protein p53 (Li-Fraumeni syndrome) |
| 7167 | 2 | 21991 | TPI1 | Hemolytic anemia due to triosephosphate isomerase deficiency | 190450 | 11 | 12p13 | triosephosphate isomerase 1 |
| 7168 | 9 | 22003 | TPM1 | Cardiomyopathy, familial hypertrophic, 3 | 191010 | 4 | 15q22.1 | tropomyosin 1 (alpha) |
| 7172 | 1 | 22017 | TPMT | 6-mercaptopurine sensitivity | 187680 | 12 | 6p22.3 | thiopurine S-methyltransferase |
| 7173 | 7 | 22018 | TPO | Thyroid hormone organification defect IIA | 606765 | 9 | 2p25 | thyroid peroxidase |
| 7227 | 1 | 83925 | TRPS1 | Trichorhinophalangeal syndrome, type III | 604386 | 4 | 8q24.12 | trichorhinophalangeal syndrome I |
| 7248 | 4 | 64930 | TSC1 | Lymphangioleiomyomatosis | 605284 | 3 | 9q34 | tuberous sclerosis 1 |
| 7251 | 1 | 22088 | TSG101 | Breast cancer | 601387 | 3 | 11p15 | tumor susceptibility gene 101 |
| 7253 | 7 | 22095 | TSHR | Graves disease | 603372 | 5 | 14q31 | thyroid stimulating hormone receptor |
| 7274 | 2 | 50500 | TTPA | Ataxia with isolated vitamin E deficiency | 600415 | 3 | 8q13.1-q13.3 | tocopherol (alpha) transfer protein (ataxia (Friedreich-like) with vitamin E deficiency) |
| 7276 | 4 | 22139 | TTR | Amyloid neuropathy, familial, several allelic types | 176300 | 11 | 18q12.1 | transthyretin (prealbumin, amyloidosis type I) |
| 7287 | 4 | 22157 | TULP1 | Retinitis pigmentosa-14 | 602280 | 3 | 6p21.3 | tubby like protein 1 |
| 7299 | 2 | 22173 | TYR | Albinism, oculocutaneous, type IB | 606933 | 7 | 11q14-q21 | tyrosinase (oculocutaneous albinism IA) |
| 7306 | 2 | 22178 | TYRP1 | Albinism, rufous | 115501 | 3 | 9p23 | tyrosinase-related protein 1 |
| 7337 | 6 | 22215 | UBE3A | Angelman syndrome | 601623 | 21 | 15q11-q13 | ubiquitin protein ligase E3A (human papilloma virus E6-associated protein, Angelman syndrome) |
| 7372 | 3 | 22247 | UMPS | Oroticaciduria | 258900 | 8 | 3q13 | uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase) |
| 7389 | 2 | 22275 | UROD | Porphyria, hepatoerythropoietic | 176100 | 9 | 1p34 | uroporphyrinogen decarboxylase |
| 7399 | 2 | 22283 | USH2A | Retinitis pigmentasa, AR, without hearing loss | 276901 | 3 | 1q41 | Usher syndrome 2A (autosomal recessive, mild) |
| 7421 | 1 | 22337 | VDR | Rickets, vitamin D-resistant | 601769 | 4 | 12q12-q14 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 7439 | 1 | 24115 | VMD2 | Macular dystrophy, vitelliform type | 153700 | 5 | 11q13 | vitelliform macular dystrophy (Best disease, bestrophin) |
| 7450 | 7 | 22371 | VWF | von Willebrand disease | 193400 | 11 | 12p13.3 | von Willebrand factor |
| 7486 | 2 | 22427 | WRN | Werner syndrome | 604611 | 4 | 8p12-p11.2 | Werner syndrome |
| 7498 | 8 | 22436 | XDH | Xanthinuria, type I | 278300 | 4 | 2p23-p22 | xanthene dehydrogenase |
| 7504 | 7 | 22439 | XK | McLeod phenotype | 314850 | 5 | Xp21.1 | Kell blood group precursor (McLeod phenotype) |
| 7507 | 1 | 22590 | XPA | Xeroderma pigmentosum, group A | 278700 | 4 | 9q22.3 | xeroderma pigmentosum, complementation group A |
| 7508 | 2 | 22591 | XPC | Xeroderma pigmentosum, group C | 278720 | 4 | 3p25 | xeroderma pigmentosum, complementation group C |
| 7535 | 7 | 22637 | ZAP70 | Selective T-cell defect | 176947 | 2 | 2q12 | zeta-chain (TCR) associated protein kinase 70kDa |
| 7546 | 6 | 22772 | ZIC2 | Holoprosencephaly-5 | 603073 | 2 | 13q32 | Zic family member 2 (odd-paired homolog, Drosophila) |
| 7547 | 6 | 22773 | ZIC3 | Heterotaxy, X-linked visceral | 300265 | 2 | Xq26.2 | Zic family member 3 heterotaxy 1 (odd-paired homolog, Drosophila) |
| 7555 | 253 | 12785 | ZNF9 | Myotonic dystrophy, type 2 | 602668 | 5 | 3q21 | zinc finger protein 9 (a cellular retroviral nucleic acid binding protein) |
| 7704 | 91 | 22659 | ZNF145 | Leukemia, acute promyelocytic, PL2F/RARA type | 176797 | 5 | 11q23.1 | zinc finger protein 145 (Kruppel-like, expressed in promyelocytic leukemia) |
| 7750 | 2 | 76007 | ZNF198 | Stem-cell leukemia/lymphoma syndrome | 602221 | 6 | 13q11-q12 | zinc finger protein 198 |
| 7827 | 2 | 170484 | NPHS2 | Nephrotic syndrome, steroid-resistant | 604766 | 3 | 1q25-q31 | nephrosis 2, idiopathic, steroid-resistant (podocin) |
| 7849 | 5 | 18510 | PAX8 | Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia | 167415 | 11 | 2q12-q14 | paired box gene 8 |
| 7873 | 2 | 74840 | ARMET | Pancreatic cancer | 601916 | 2 | 3p21.1 | arginine-rich, mutated in early stage tumors |
| 7913 | 4 | 110052 | DEK | Leukemia, acute nonlymphocytic | 125264 | 3 | 6p23 | DEK oncogene (DNA binding) |
| 7915 | 10 | 110782 | ALDH5A1 | Succinic semialdehyde dehydrogenase deficiency | 271980 | 4 | 6p22 | aldehyde dehydrogenase 5 family, member A1 (succinate-semialdehyde dehydrogenase) |
| 7941 | 3 | 27226 | PLA2G7 | Platelet-activating factor acetylhydrolase deficiency | 601690 | 3 | 6p21.2-p12 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
| 8013 | 2 | 18124 | NR4A3 | Chondrosarcoma, extraskeletal myxoid | 600542 | 7 | 9q22 | nuclear receptor subfamily 4, group A, member 3 |
| 8029 | 1 | 65969 | CUBN | Megaloblastic anemia-1 | 602997 | 2 | 10p12.31 | cubilin (intrinsic factor-cobalamin receptor) |
| 8089 | 5 | 64050 | Glioma | 602116 | 3 | 12q13-q15 | glioma-amplified sequence-41 | |
| 8106 | 1 | 54196 | PABPN1 | Oculopharyngeal muscular dystrophy, autosomal recessive | 602279 | 2 | 14q11.2-q13 | poly(A) binding protein, nuclear 1 |
| 8139 | 12 | 116910 | GAN | Giant axonal neuropathy-1 | 605379 | 2 | 16q24.1 | giant axonal neuropathy (gigaxonin) |
| 8195 | 3 | 59030 | MKKS | Bardet-Biedl syndrome 6 | 604896 | 5 | 20p12 | McKusick-Kaufman syndrome |
| 8200 | 1 | 14563 | GDF5 | Acromesomelic dysplasia, Hunter-Thompson type | 601146 | 4 | 20q11.2 | growth differentiation factor 5 (cartilage-derived morphogenetic protein-1) |
| 8277 | 6 | 83553 | TKTL1 | ?Wernicke-Korsakoff syndrome, susceptibility to | 300044 | 2 | Xq28 | transketolase-like 1 |
| 8291 | 13 | 26903 | DYSF | Myopathy, distal, with anterior tibial onset | 603009 | 5 | 2p13.3-p13.1 | dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive) |
| 8468 | 1 | 94244 | FKBP6 | 604839 | 3 | 7q11.23 | FK506 binding protein 6, 36kDa | |
| 8557 | 1 | 21393 | TCAP | Muscular dystrophy, limb-girdle, type 2G | 604488 | 6 | 17q12 | titin-cap (telethonin) |
| 8625 | 4 | 19727 | RFXANK | MHC class II deficiency, complementation group B | 603200 | 7 | 19p12 | regulatory factor X-associated ankyrin-containing protein |
| 8647 | 12 | 27413 | ABCB11 | Progressive intrahepatic cholestasis-2 | 603201 | 3 | 2q24 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
| 8898 | 11 | 77116 | MTMR2 | Charcot-Marie-Tooth disease, type 4B | 603557 | 4 | 11q22 | myotubularin related protein 2 |
| 9031 | 3 | 22385 | BAZ1B | 605681 | 6 | 7q11.23 | bromodomain adjacent to zinc finger domain, 1B | |
| 9056 | 12 | 20540 | SLC7A7 | Lysinuric protein intolerance | 603593 | 5 | 14q11.2 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 |
| 9132 | 2 | 60613 | KCNQ4 | Deafness, autosomal dominant 2 | 603537 | 3 | 1p34 | potassium voltage-gated channel, KQT-like subfamily, member 4 |
| 9381 | 9 | 83762 | OTOF | Deafness, autosomal recessive 9 | 603681 | 4 | 2p23.1 | otoferlin |
| 9444 | 1 | 19317 | 7 | 6q26-27 | ortholog of mouse quaking QKI (KH domain RNA binding protein) | |||
| 9445 | 8 | 16432 | ITM2B | Dementia, familial British | 603904 | 5 | 13q14.3 | integral membrane protein 2B |
| 9993 | 3 | 13356 | DGCR2 | 600594 | 5 | 22q11.21 | DiGeorge syndrome critical region gene 2 | |
| 10512 | 29 | 20348 | SEMA3C | 602645 | 2 | 7q21-q31 | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | |
| 10539 | 3 | 30926 | TXNL2 | 5 | 6p25.3 | thioredoxin-like 2 | ||
| 10560 | 1 | 116914 | SLC19A2 | Thiamine-responsive megaloblastic anemia syndrome | 603941 | 4 | 1q23.3 | solute carrier family 19 (thiamine transporter), member 2 |
| 10577 | 3 | 67963 | NPC2 | Niemann-pick disease, type C2 | 601015 | 3 | 14q24.3 | Niemann-Pick disease, type C2 |
| 10682 | 3 | 13595 | EBP | Chondrodysplasia punctata, X-linked dominant | 300205 | 6 | Xp11.23-p11.22 | emopamil binding protein (sterol isomerase) |
| 10804 | 7 | 14623 | GJB6 | Deafness, nonsyndromic neurosensory, digenic | 604418 | 2 | 13q12 | gap junction protein, beta 6 (connexin 30) |
| 10913 | 1 | 13608 | EDAR | Ectodermal dysplasia, hypohidrotic, autosomal recessive | 604095 | 3 | 2q11-q13 | ectodysplasin 1, anhidrotic receptor |
| 11081 | 11 | 16545 | KERA | Cornea plana congenita, recessive | 603288 | 4 | 12q22 | keratocan |
| 11136 | 9 | 30962 | SLC7A9 | Cystinuria, type II | 604144 | 4 | 19q13.1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 |
| 23095 | 22 | 16561 | KIF1B | Charcot-Marie-Tooth neuropathy, type 2A | 605995 | 3 | 1p36.2 | kinesin family member 1B |
| 23418 | 9 | 170788 | CRB1 | Leber congenital amaurosis | 604210 | 4 | 1q31-q32.1 | crumbs homolog 1 (Drosophila) |
| 26121 | 6 | 68988 | PRPF31 | Retinitis pigmentosa-11 | 606419 | 4 | 19q13.42 | PRP31 pre-mRNA processing factor 31 homolog (yeast) |
| 50964 | 1 | 74499 | SOST | Sclerosteosis | 605740 | 4 | 17q12-q21 | sclerosteosis |
| 51062 | 10 | 73991 | SPG3A | Spastic paraplegia-3A | 606439 | 4 | 14q21.3 | spastic paraplegia 3A (autosomal dominant) |
| 51168 | 23 | 17910 | MYO15A | Deafness, autosomal recessive 3 | 602666 | 2 | 17p11.2 | myosin XVA |
| 54840 | 5 | 66408 | APTX | Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | 606350 | 3 | 9p13.3 | aprataxin |
| 55806 | 1 | 15460 | HR | Atrichia with papular lesions | 602302 | 5 | 8p21.2 | hairless |
| 57192 | 9 | 94178 | MCOLN1 | Mucolipidosis IV | 605248 | 7 | 19p13.3-p13.2 | mucolipin 1 |
| 57379 | 1 | 11628 | AICDA | Immunodeficiency with hyper-IgM, type 2 | 605257 | 4 | 12p13 | activation-induced cytidine deaminase |
| 57679 | 4 | 74018 | ALS2 | Amyotrophic lateral sclerosis, juvenile | 606352 | 5 | 2q33.2 | amyotrophic lateral sclerosis 2 (juvenile) |
| 64072 | 37 | 22295 | CDH23 | Deafness, autosomal recessive 12 | 605516 | 7 | 10q21-q22 | cadherin related 23 |
| 64327 | 4 | 56873 | C7orf2 | Acheiropody | 605522 | 5 | 7q36 | chromosome 7 open reading frame 2 |
| 64699 | 7 | 140765 | TMPRSS3 | Deafness, autosomal recessive 8, childhood onset | 605511 | 10 | 21q22.3 | transmembrane protease, serine 3 |
| 64805 | 8 | 70839 | Platelet ADP receptor defect | 600515 | 5 | 3q24-q25 | Purinergic receptor P2Y, G protein-coupled, 12 | |
| 65217 | 2 | 11994 | PCDH15 | Usher syndrome, type 1F | 605514 | 3 | 10q21.1 | protocadherin 15 |
| 93986 | 7 | 114142 | FOXP2 | Speech-language disorder-1 | 605317 | 3 | 7q31 | forkhead box P2 |